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Cardiovascular diseases has become the major cause of death globally. Inflammation 
and platelet aggregation play crucial role in the development and progression of 
atherosclerosis and CVD. prevent inflammation, atherosclerosis, and endothelial 
dysfunction and ultimately cardiovascular events. Fish and especially oily fish such as 
Salmon are vital components of healthy dietary patterns with preventive properties 
against CVD. Raw salmon contain bioactive polar lipids (PLs) with strong 
antithrombotic bioactivities. However, salmon is mainly consumed cooked. The aim of 
the present study was to evaluate for the first time the effects of the emerging mild sous 
vide cooking processing on the antithrombotic properties, lipid content and sensory 
characteristics of salmon. 
Total lipids (TLs) were extracted from brined and un-brined salmon sous vide 
preparations in several temperatures (52°C, 65°C and 80°C) and further separated into 
the Neutral Lipids (NLs) and PLs fractions. The antithrombotic properties of salmon 
PLs were tested in human platelets, while their fatty acid content was determined by 
LC-MS analysis. Sensory tests were performed using napping followed by check-all-
that apply. Sous vide salmon preparations in all conditions did not affect the taste, 
whereas in 65°C and 80°C slight textural differences were observed. Mild sous vide 
cooking of brined or un-brined salmon in low temperatures (52-65°C) did not affect the 
potent inhibitory effect of salmon PLs against human platelet aggregation induced by 
the inflammatory and thrombotic mediators’ platelet-activating factor (PAF) and 
thrombin, but also by the well-established platelet agonists adenosine diphosphate 
(ADP) and collagen. Sous vide preparations of both brined and un-brined salmon in 
higher temperatures, such as those usually applied for pasteurization (80°C), resulted in 
reduction of these antithrombotic properties of salmon. This was accompanied by a 
reduction of the EPA and DHA content of the salmon in these conditions in the un-
brined sous vide preparations. Nevertheless, the antithrombotic properties of salmon 
PLs were preserved in considerable potency even when high temperatures were applied 
for the sous vide salmon preparations. This outcome if combined with the observed low 
values of the n-6/n-3 ratio of the PUFA content in the salmon PLs of all sous vide 
preparations, further suggest a beneficial role for such a mild cooking procedure for 
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1.1 The key role of Inflammation and platelet aggregation in         
Chronic Disorders, with emphasis to cardiovascular diseases 
The global burden of systemic chronic diseases such as obesity and type 2 diabetes 
mellitus, cardiovascular disease (CVD), cancer, etc. is constantly rising, resulting in 
significant losses of life and disability adjusted life years in both developing and 
developed countries (Mathers and Loncar, 2006). The World Health organisation (WHO 
2017) has estimated that one in three global deaths is because of CVD related events 
such as myocardial infarction and stroke (WHO). In 2017, WHO released figures stating 
that approximately 17.7 million global deaths were due to CVD-related events (WHO). 
According to Irelands Health Service Executive, approximately 10,000 Irish people die 
each year as a result of CVD, including coronary heart disease (CHD), stroke and other 
circulatory diseases (Tsoupras et al., 2018a). According to the American Heart 
Association, a similar worldwide trend exists. CVD globally accounts for more than 
17.3 million deaths annually which is predicted to rise even further to 23.6 million by 
the year 2030 (WHO 2017). Looking at these numbers, it is evident that the 
development and effects of CVD is of major concern worldwide. 
It is now widely regarded that one of the underlying mechanisms at cellular and 
molecular level, which is related to a common mechanistic pathway of the initiation and 
progression of several chronic diseases is chronic inflammation and in particular, that 
affecting the endothelium  (Tsoupras et al., 2019a). 
Inflammation and platelet aggregation represent a physiological reaction of the innate 
immune system in order to maintain and protect a constant internal milieu while being 
exposed to continuously changing environmental pressures, irrespective of whether the 
initial causes originate from microbial infection, traumatic injury or metabolic 
dysfunction The inflammatory response aims to reduce the agent that causes tissue 
injury (and/or minimise these effects) to induce appropriate wound healing and repair 
programs while restoring tissue homeostasis. 
The inflammatory response occurs when the innate immune cells such as blood 
leukocytes, mast and dendrite cells are activated. Activated immune cells produce 
various toxic agents such as reactive oxygen species (ROS), reactive nitrogen species 
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(RNS), elastases, cathepsins, eicosanoids, proteinases, but also inflammatory and 
thrombotic mediators such as platelet activating factor (PAF) and thrombin and platelet 
agonists such as collagen and ADP (Adenosine diphosphate). All the above can induce 
or suppress inflammation, depending on the initial stimuli and of the phase of 
inflammatory injury (Li et al., 2010, Tsopanoglou and Maragoudakis, 2009).  Provided 
that the immune response succeeds in eliminating the infectious agents or repairing the 
initial tissue injury, the inflammatory process will be terminated at an appropriate time 
and therefore only marginally affect tissue function. 
However, in cases where the inflammation fails to resolve, for example, due to 
persistence of a pathogen or the unsuccessful repairing of the initiating injury and tissue 
dysfunction, a sustained underlying inflammatory process develops, leading to tissue 
dysfunctions and detrimental consequences for the established chronic inflammatory 
condition (Chen et al., 2017). Chronic and unresolved inflammatory manifestations that 
accumulate in the walls of arteries trigger the onset of atherosclerosis, a chronic 
developing vascular disease (Rafieian-Kopaei et al., 2014, Tsoupras et al., 2018b, 
Tsoupras et al., 2019b) Upon progression, this disease may lead to ensuing major 
cardiovascular events (Demopoulous et al., 2003; (Tsoupras et al., 2018b). 
Atherosclerosis is widely regarded as the principal cause of CVD-related events that 
lead to morbidity and mortality. It is apparent that inflammation, thrombosis and 
platelet activation-aggregation play vital role in all stages of the formation of vascular 
lesions perpetuated and intensified by risk factors such as diet, lifestyle, smoking, 
autoimmune diseases, hypertension etc (Demopoulos et al., 2003, Tsoupras et al., 
2018b) . Therefore, healthy dietary patterns have been proposed for both Primordial and 
Primary prevention to prevent inflammation, atherosclerosis, and endothelial 
dysfunction from taking hold, and thus reduce risk and ultimately cardiovascular events 




Figure 1. Flow diagram of the Development of CVD and Possible Prevention by a 
healthy diet (Yu et al., 2018).  
 
1.2 . The benefits of Healthy dietary patterns and fish intake 
Nutrition notably should be regarded as a lifestyle issue and implemented as a vital 
biochemical tool against the formation of such chronic diseases as CVD (Tierney et al., 
2019, Tsoupras et al., 2018b). The cross-talk of pathways of several inflammatory and 
thrombotic mediators, but also of platelet aggregation agonists such as PAF, thrombin, 
collagen and ADP has been implicated in these chronic disorders (Tsoupras et al., 
2018b). Diet has been found to influence these pathways either detrimentally 
(Westernised Diet) or beneficial (Mediterranean Diet) (Tierney et al., 2019, Tsoupras et 
al., 2018b). 
Over the last 5 years, the beneficial outcomes of the adoption of the Mediterranean Diet 
(Med-diet) have come to prominence (Tierney et al., 2019). The Med-diet and its 
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cardioprotective attributes has been attributed to several of its pleiotropic protective 
effects (Tierney et al., 2019, Tsoupras et al., 2018b) The beneficial effects of the Med-
diet include reduction in insulin resistance, reduction of lipid levels, lowering of BMI 
and blood pressure and the improvement of HDL-cholesterol functionality ((Tierney et 
al., 2019, Tsoupras et al., 2018b). Notably, the primary beneficial effect of the Med-diet 
is on the amelioration of endothelial functionality and the decrease of the inflammatory 
milieu, inflammatory- related mediators, biomarkers such as platelet-activation factor 
(PAF), and several other (Tsoupras et al., 2018b). Moreover, it has been proposed that 
there are beneficial effects on oxidative stress, with lower concentrations of oxidised 
LDL and improved apolipoprotein profiles, and, in conclusion, evidence exists of the 
beneficial effects against platelet aggregation and blood coagulation (Tierney et al., 
2019, Tsoupras et al., 2018b). It is now well established that several micro-constituents 
of the Med-Diet affect platelet aggregation and activation of inflammatory pathways 
and cells by their effects on the receptors and/or on the metabolism of the mediators 
involved in these pathways, such as the PAF-pathway (Figure 1). 
Fish is one of the main animal-origin constituents of such healthy dietary patterns. The 
nutritional guidelines of healthy dietary patterns favours fish-consumption twice per 
week or once a week for oily fish such as salmon and sardines (Goel et al., 2018). 
For example, in the ATTICA study fish consumption exhibited favourable effects 
against CVD (Zampelas et al., 2005). More specifically, the dietary pattern in this study 
that was mainly characterized by cereals, small fish, hardtack and olive oil intake, was 
associated with lower CVD risk (Zampelas et al., 2005). In addition, meta-analysis of 
observational studies investigating fish consumption and the correlation with incidences 
of coronary heart disease mortality concluded that individuals whom consume fish had 
a 15% reduced risk in comparison to individuals who did not consume fish (He et al., 
2004). Moreover, the consumption of fish and fish oils is also associated with an 
improvement of platelet functionality in CVD and several other inflammation related 
disorders (Mori, 2017, Goel et al., 2018, Tsoupras et al., 2019c, Tsoupras et al., 2018c, 






Figure 1.1. An image demonstrating the role of PAF and PAF-R in response to 
inflammatory stimuli.  
(A1) Pro-inflammatory stimuli stimulate the syntheses of PAF and the expression of PAF-
R on the surface of cells which can result in the amplification of certain pro-inflammatory 
stimuli. (A2) The binding of PAF to PAF-R signals the initiation of several inflammatory 
responses such as the release of PAF from the activated cells and the production of more 
arachidonic acid within the body to be used as a substrate in the formation of more PAF. 
(A3) Further activation of PAF-R on the surface of cells signals the release of 
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chemokines, expression of adhesion molecules on endothelial cells, and release/synthesis 
of PAF, further amplifying the inflammatory response. This results in the cellular 
signalling for the recruitment of lymphocytes to the site of inflammation where lymphatic 
cells bind to the adhesion molecules expressed on the surface of the damaged endothelial 
cells. (B)  The inflammatory cascade leads to an increase in the concentration of PAF at 
the site of inflammation and so promotes a broad spectrum of effects caused by the 
increased levels of PAF and other pro-inflammatory mediators circulating the blood. The 
increased levels of PAF, chemokines, and other inflammatory mediators in the 
bloodstream causes further activation of PAF-R. This promotes the aggregation of 
platelets and leukocytes and subsequent damage and activation of other endothelial cells 
downstream. These damaged endothelial cells promote leukocyte adherence, invasion, 
migration and subsequent endothelial dysfunction, thus stimulating the development of 
an inflammatory-related chronic disorders as seen in this image.  (C) Demonstrates how 
PAF antagonists, such as microconstituents of the Mediterranean diet, can act to disrupt 
the binding of PAF to the PAF-R. This disruption of PAF, possibly occurs by competitive 
displacement and, could aid in lowering PAF concentrations in the blood (Image 
reproduced with permission from (Tsoupras et al., 2018b). 
 
Therefore, several dietary guidelines (i.e. The US Dietary Guidelines) and healthy 
dietary patterns (i.e. the Mediterranean diet) recommend fish intake at least twice 
weekly (Lordan et al., 2017, Megson et al., 2016, Raatz et al., 2016, Tsoupras et al., 
2018a). In particular, intake of farmed Atlantic salmon twice weekly influences 
lipoprotein particle size, decreases serum concentrations of triglycerides, and increases 
HDL cholesterol in a manner associated with CVD risk reduction (Zhang et al., 2012b, 
Hagen et al., 2016, Tsoupras et al., 2018a). It has also been proposed that salmon may 
possess natural resistance mechanisms to reduce its own risk of atherosclerosis and 
cardiovascular risk, which corresponds well with its high investment in its own lipid 
metabolism and lipid profile (Tsoupras et al., 2018a, Dalum et al., 2016).  
Epidemiologic studies have shown that high dietary consumption of salmon and other 
oily fish, such as herring and trout, is associated with reduced rates of myocardial 
infarction, atherosclerosis, and other ischemic pathologies (See Appendix I). In 
addition, dietary fish oil induces changes in cardiac function that might contribute to 
cardiovascular health benefits in humans and does so by modifying cardiac membranes 
within a dose range achievable in the human diet (Gladyshev et al., 2006).  
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Although fish such as salmon can be served raw in preparations such as sushi and 
ceviche, fish is generally consumed using a cooking technique. This cooking technique 
can lead to conformational changes in the composition of the food stuff which could 
affect the nutrient content and therefore the health benefits of consumption of fish such 
as salmon. Even though the health benefits of fish-consumption and their lipid contents 
are universally recognized today by medical professionals, there is limited reviewing on 
the effects of cooking and emerging mild cooking techniques such as the sous vide. 
Especially for salmon, this mild cooking technique has recently gained a lot of attention, 
and thus the study of the effects of such a sous-vide cooking process on salmon lipid 
content, activities and bio-functionality is significant for elucidating the benefits of 
applying mild cooking techniques that can preserve the bio-functionality of fish.   
 
1.3  Salmon lipid content and bio-functionality 
Salmon has been characterised as an oily fish (Gil and Gil, 2015).  It is rich in bioactive 
lipids and thus it has been proposed as a classic beneficial fish intake in several dietary 
guidelines. Consumption of fish such as salmon regularly has been shown to have 
cardio-protective effects as its lipid content displaces intakes of pro-atherosclerotic 
foods higher in saturated fatty acids and trans fatty acids in the diet (Burri et al., 2012, 
Tsoupras et al., 2018b, Tsoupras et al., 2018a). In addition, the beneficial effects of fish 
such as salmon consumption and of related marine oils, were primarily attributed to 
their high content of n-3 polyunsaturated fatty acids (PUFA), such as the 
eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids) and their eicosanoid-
related anti-inflammatory and antiplatelet effects (Mori et al., 1997). Thus, significant 
research has focused on n-3 fatty acid EPA and DHA, which have been shown to 
demonstrate several beneficial properties for human health. 
However, apart from the n-3 content of fish, several other studies have proposed that the 
beneficial effect of fish intake on cerebrovascular risk is likely to be mediated through 
the interplay of a wide range of lipid nutrients abundant in fish (Goel et al., 2018, 
Chowdhury et al., 2012, Lordan et al., 2017). Therefore, it is important to classify the 






1.3.1. Classes of Lipids found in salmon 
Lipids are classed as an extremely diverse class of biomolecules possessing a vast array 
of functions and structures. They can be divided generally into two important 
subclasses: neutral lipids (such as triacylglycerols, fatty acids, waxes, terpenes etc.) and 
polar lipids (such as glycolipids, phospholipids etc.) that contain both a hydrophobic 
hydrocarbon residue and also a polar hydrophilic group ie. a carbohydrate group, or a 
phosphate head group which possesses a hydrophilic residue within its structure 
(Figure1.2). Salmon contains several of these lipid classes, with highly bioactive being 
mostly its fatty acid composition and polar lipid content (Tsoupras et al., 2018a, 
Tsoupras et al., 2019a) Tsoupras et al. (2018) reported total lipid value of Irish organic 
farmed salmon of 5.51±1.90g of lipids per 100g of salmon fillet which is quite higher 
than other fish species but being classified as an oily fish this is in agreement with the 
literature (Tsoupras et al., 2018a). Total lipid was further separated into total neutral 
lipid (TNL) and total polar lipid (TPL). The TNL value was 4.66±2.08g of lipids per 
100g of salmon fillet whereas the TPL value 0.86±0.36g.  
 
Figure 1.2 (A) Structural representation of a triglyceride molecule. (B) Structural 
representation of a glycerol-based polar lipid molecule; the polar lipid structure bears 
two hydrophobic, hydrocarbon chains esterified to the glycerol backbone in the sn-1 and 
sn-2 position, with a charged phosphate group at the sn-3 position. (C) Classic 
sphingosine-based polar lipid. (D) Alkyl-acyl-glycerol based polar lipids (Image 




1.3.2 Fatty acid composition of salmon; Bioactive FA in salmon 
Knowledge of the FA composition of commercially important fish species such as 
salmon is required owing to the post mortem deterioration and changes of the nutritional 
value of fish. The fish lipid composition also has applications in food, health care, 
pharmaceutical products and as ingredients in feed in agriculture and the aquaculture 
industry (Moroney et al., 2015). 
The fatty acid composition of salmon as reviewed by several research teams is 
presented in Table 1.1. More specifically, it was reported that in raw King Salmon, the 
most abundant fatty acids were MUFA which accounted for 43.8% of total fatty acids 
followed by PUFA accounting for 28.23% and SFA 27.97% of total fatty acid. In the 
raw salmon samples, oleic acid was present in the highest quantity (32.36%). The 
dominant PUFA was linoleic acid being the most abundant n-6 fatty acid (9.54%). DHA 
(7.36%) was the most dominant n-3 fatty acid present followed by EPA (5.7%). 
Palmitic acid (17.9%) and stearic acid (5.26%) were the most dominant SFA present in 
the raw salmon samples (Larsen et al., 2010). The composition of the fatty acids in raw 
salmon in this article were similar with results obtained by other authors (Bastias et al., 
2017, Şengör et al., 2013). Larsen et al., 2010 furthermore  reputed a n-6/n-3 of 0.68 
which was in accordance with other authors (Bastias et al., 2017) but lower than the 
findings of (Şengör et al., 2013, Al-Saghir et al., 2004).   
Table 1.1. Fatty acid composition of raw salmon. 
Raw 
Salmon 
Larsen et al. 
2010* 
Bastias et al. 
2017* 




SFA 27.97 26.58 17.49 15.90 
MUFA 43.80 44.7 39.64 53.70 
Oleic Acid 32.36 36.44 31.39 23.00 
PUFA 28.23 26.74 28.47 30.20 
n-3 15.91 15.9 14.66 17.10 
EPA 5.70 5.83 4.81 4.30 
DHA 7.36 7.64 5.74 6.70 
n-6 10.89 10.84 12.56 9.30 
n-6/n-3† 0.68 0.68 0.85 1.26 
*Results are expressed as expressed as a percentage of the total fatty acid. † The ratio of 
the total amount of n-6 fatty acids divided by the total amount of n-3 fatty acids. 
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Consumption of oily fish such as salmon that is rich in n-3 PUFA such as DHA and 
EPA has been associated with several health benefits, such as improved platelet 
functionality and cardiovascular health (Mori et al., 1997, Mori, 2018, Goel et al., 
2018) while a low value of the ratio of n-6/n-3 PUFA in a diet seems also to provide 
several beneficial health outcomes in CVD and other chronic disorders (Simopoulos, 
2002). These effects were primarily attributed to their high content of n-3 
polyunsaturated fatty acids (PUFA), such as eicosapentaenoic acid (EPA) and 
docosahexaenoic (DHA) acid, and their eicosanoid-related antiplatelet effects (Mori, 
2018). 
A significant number of studies on the health benefits of n-3 PUFAs have been assessed 
(Ferraro et al., 2013, Bhatt et al., 2019a, Bhatt et al., 2019b). These fatty acids are 
classed as “essential fatty acids” as they must be obtained via the diet and in particular, 
the consumption of fish and fish oils rich in such fatty acids. The consumption of the 
aforementioned fatty acids is essential in the maintenance of homeostasis. It is reported 
that EPA is an initial substrate for resolving and eicosanoid synthesis.  
The initial studies on the health benefits of n-3 PUFAs originates in the early 1970’s 
when Dyerberg and Bang observed the effects of fish consumption amongst the 
Greenland Eskimos and its correlation with incidences of atherosclerosis and 
thrombosis (Dyerberg et al., 1975). Further studies have demonstrated the importance 
of n-3 PUFAs at cellular levels for maintaining membrane homeostasis, its influence on 
gene expression and its vital importance for an optimal balance with n-6 FA to regulate 
the inflammatory response (Tierney et al., 2019). 
More specifically, EPA has universally-accepted antiplatelet effects (Thorngren and 
Gustafson, 1981), whereas DHA is a structural fatty acid in nervous tissues such as the 
brain and the retina (Tierney et al., 2019, Goel et al., 2018, Ferraro et al., 2013). Recent 
studies have also shown that supplements of EPA at high doses (4 g/day) reduce both 
major adverse cardiovascular events (MACE) and hard endpoints in the REDUCE-IT 
clinical trial (Reduction of Cardiovascular Events With Icosapent Ethyl–Intervention 
Trial) (Bhatt et al., 2019b), while EPA reduced both first events and recurrent events 
(Bhatt et al., 2019b). Interestingly, the protective effects of n-3 fatty acids are more 
evident in patients with low fish consumption (as shown in the VITAL clinical trial 
(Vitamin D and Omega-3 Trial) (Manson et al., 2019). 
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On the other hand, there are several recent reviews and meta-analyses highlighting that 
marine oil n-3 PUFA supplements (as purified fatty acids or esters and triglycerides) do 
not affect the risk of major adverse cardiac events, cancer and all-cause death (Goel et 
al., 2018, Manson et al., 2019, Rizos et al., 2012, Enns et al., 2014, Walz et al., 2016, 
Kwak et al., 2012, Chowdhury et al., 2012, Lordan et al., 2017). Furthermore, some of 
these studies suggest that the observed beneficial effects of fish and fish oils are likely 
to be mediated through the interplay of other beneficial lipid nutrients (Lordan et al., 
2017, Goel et al., 2018, Chowdhury et al., 2012). 
The therapeutic dose of n-3 fatty acids depends not only on the degree of disease 
severity, but also on the form that these essential lipids are consumed, with different 
digestion mechanisms and bioavailability in cell membranes and lipoproteins (Goel et 
al., 2018, Lordan et al., 2017, Burri et al., 2012, Davidson et al., 2012). 
Marine DHA or EPA themselves are usually moieties of lipid molecules such as esters, 
triglycerides (TG), or polar lipids (e.g., phospholipids and glycolipids). Although the 
most abundant DHA- or EPA-rich lipid class in most marine by-products is TG, some 
of the fisheries by-product sources or poorly-used marine resources are rich in DHA- or 
EPA-containing phospholipids that are often called marine phospholipids (Vázquez et 
al., 2019). TG and esters are typical hydrophobic compounds, while on the other hand, 
phospholipids are amphiphilic compounds. For this reason, the phospholipid form of 
DHA and EPA are considered to be much more bioactive and bioavailable than those of 
TG and esters, but also more effective in delivering the desired PUFA to the desired 
tissue when administrated, especially in difficult to reach tissues such as the brain 
because they can surpass the blood–brain barrier (Lordan et al., 2017, Tsoupras et al., 
2019a, Tsoupras et al., 2018a, Burri et al., 2012, Takahashi and Inoue, 2012).  
Within this concept, promising outcomes have been attributed to polar lipids (PLs) of 
marine origin (Lordan et al., 2017), especially to those bearing ω3 PUFA within their 
structure (Lordan et al., 2017, Tsoupras et al., 2019a, Tsoupras et al., 2018a, Burri et 
al., 2012, Davidson et al., 2012, Bjorndal et al., 2014), with strong anti-inflammatory, 
antithrombotic, and cardioprotective activities potentially mediated through anti-PAF 
and anti-thrombin effects (Tsoupras et al., 2018b, Lordan et al., 2017, Tsoupras et al., 
2019a, Tsoupras et al., 2018a, Nasopoulou et al., 2011, Kalogeropoulos et al., 2008, 




1.3.3 Salmon Polar Lipids 
The classes of PLs of importance are sphingoPLs, ether glycerolipids and glyceroPLs. 
Glycerolipids can be further separated into different subgroups defined by the head group 
located in the PL. The head group can comprise of serine, inositol, choline, glycerol or 
ethanolamine. The most common PLs in marine sources are phosphatidycholine (PC), 
which consists of a choline head group and phosphatidylethanolamine (PE), which 
contains an ethanolamine head group. Phosphatidylinositol, lysophosphatidylcholine, 
phosphatidylserine and sphingomyelin are found to lesser extents in marine sources. 
Generally, oily fish such as mackerel, herring and salmon are the most predominant 
sources of marine PLs (Lordan et al., 2017). 
Salmon contain between 0.5-1.3g of polar lipids per 100g of fillet tissue (Tsoupras et 
al., 2018a).  The most abundant polar lipids present in fatty oily fish such as herring and 
salmon are derivatives of phosphatidylcholine (PC), the second most predominant been 
phosphatidylethanolamine (PE) followed by phosphatidylinositol (PI), 
 Phosphatidylserine (PS), lysophosphatidylcholine (lyso-PC) and sphingomyelin are 
also present but in lesser quantities (Lordan et al., 2017) Notably, the principal PLs 
class of oily fish such as salmon derived PLs is PC, typically binding with unsaturated 
omega-3 PUFAs, predominantly EPA and DHA and to a lesser extent stearidonic acid 








Figure 1.3. (A) Typical structure of a PAF molecule. (B) Image representing biologically 
active phospholipids. (C) Image representing biologically active salmon PL bearing EPA 
and DHA within their structures. Reproduced with modifications after permission from 
Dr Tsoupras (Tsoupras et al., 2019a). 
Unlike n-3 PUFAs, salmon phospholipids are not so susceptible to oxidation. This is 
possibly due to the natural presence of antioxidants such as astaxanthin which is 
extracted with various other lipids and PLs (Raatz et al., 2016).  
Marine PLs, including those derived from salmon, especially those bearing n-3 PUFA 
within their structure (Lordan et al., 2017, Tsoupras et al., 2019a, Tsoupras et al., 
2018a, Burri et al., 2012),  have exhibited promising outcomes against inflammation, 
thrombosis, platelet aggregation and related chronic disorders (Lordan et al., 2017). 
Such marine PL possess a plethora of beneficial bioactivities against inflammation-
related disorders and high bioavailability of their bioactive n-3 PUFA into plasma 
lipoproteins, cell membranes, and several tissues, including those with difficult 
accessibility such as the brain (Tsoupras et al., 2018b, Lordan et al., 2017, Tsoupras et 
al., 2019a, Tsoupras et al., 2018a, Tierney et al., 2019, Burri et al., 2012, Davidson et 
al., 2012, Bjorndal et al., 2014). Marine PLs also possess strong anti-inflammatory, 
antithrombotic, and cardioprotective activities against platelet-activating factor (PAF)-
related pathways and metabolism (Tsoupras et al., 2018b, Lordan et al., 2017, Tsoupras 
et al., 2019a, Tsoupras et al., 2018a, Nasopoulou et al., 2011), but also against the 
thrombin pathways (Tsoupras et al., 2019a, Tsoupras et al., 2018a, Kalogeropoulos et 
al., 2008, Antonopoulou et al., 2005). Recently salmon PLs have also been found to 
possess strong anti-platelet effects against well renowned platelet agonists too, such as 




However, to our knowledge there aren’t any reports studying the effects of cooking on 
the lipid content and bio-functionality and lipid content of salmon PLs and marine PLs 
in general. 
 
1.4 Cooking and its effects on lipid content in fish 
It is generally accepted that due to consumers requirements, fish is generally consumed 
cooked. During cooking, physical and chemical reactions take place that may impair or 
improve the nutritional value of the foodstuff. Cooking induces the loss of water from 
the food, which in turn, increases the lipid content in the majority of cases, but in some 
instances, fat is lost in foods with a high fat content. Traditional cooking methods such 
as frying, steaming and pan-frying are used worldwide but an emerging cooking method 
has gained popularity over the past decade: sous vide. Harsh cooking methods such as 
the traditional cooking methods tend to degrade EPA and DHA due to the high 
temperatures generated which consequently leads to the breaking of double bonds 
leading to oxidation (Adili et al., 2018).  The generation of such high temperatures 
generated during these cooking processes tends to increase the formation of free radicals 
and reactive oxygen species (ROS) and consequently results in the release of peroxides 
(Adili et al., 2018) Aldehydes and various alcohol-derived compounds of the 
hydroperoxide primary metabolites are released upon further oxidation. One such 
product are the isoprostanes which are prostaglandin-like compounds formed upon the 
free radical catalysed peroxidation of arachidonic acid. The formation of such 
compounds are generally regarded as biomarkers for oxidative stress leading to various 
diseases (Adili et al., 2018). 
The effect of various common consumer cooking techniques (raw, poached, steamed, 
oven -baked, and pan-fried with no added oil) was investigated on New Zealand King 
Salmon and the effects on the fatty acid profile. The fatty acid profile showed only 
minor differences between the different cooking methods (Larsen et al., 2010). In 
addition, oven baking salmon does not decrease the n-3 PUFA contents, indicating that 
baking salmon is an acceptable means of preparation that does not alter the potential 
health benefits of high n-3 seafood consumption (Raatz et al., 2011, Tsoupras et al., 
2018a). However, the pan-fried and oven baked King Salmon had higher % yields of 
extractable lipids than the control sample (no fat was added in either thermal 
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procedure). It was hypothesised that the increase in the extractable lipid was due to 
greater moisture loss during cooking.  
It was observed that significant increases in the fatty acid content and fat content was  
due to the dehydration during thermal treatment (Al-Saghir et al., 2004). They also 
reported no significant changes in total amounts of SFA, MUFA or PUFA. During 
thermal treatments, fatty acids behave differently. In general, SFA are reasonably heat 
stable below temperatures of 150ºC but once in excess of this temperature and in the 
presence of oxygen, oxidation tends to occur (Sioen et al., 2006) 
Unsaturated fatty acids tend to be more heat labile. However, an increase in the degree 
of unsaturation leads to less stability, therefore PUFAs are the less stable fatty acid class 
(Sioen et al., 2006). Fish lipids possess significant quantities of long chain PUFAs. The 
application of heat, including cooking, has been reported to increase the susceptibility 
of n-3 PUFA oxidation (Regulska-Ilow and Ilow, 2002). Larsen et al. (2010) reported 
that after all thermal treatments (steamed, oven-baked and pan-fried), MUFAs were the 
most abundant fatty acids and was dominated by oleic acid. No significant differences 
in MUFA content was observed between the control and cooked samples. In relation to 
PUFA content, similar levels were observed between cooked and the control (raw) 
salmon. SFA levels were similar in both cooked and the control samples. No significant 
differences in percentages of DHA, EPA or DPA was observed across the thermal 












Table: 1.4.  The effects of cooking on the lipid content of salmon using various 
conventional cooking techniques. The results are presented as %s of Total Fatty Acids. 
  All values are expressed as % of Total Fatty Acids 
 
The effects of steamed and oven-baked cooking on the fatty acid profile of salmon were 
examined and it was concluded that no significant difference was observed when 
compared to raw salmon. However, omega-3 fatty acids exhibited significant changes in 
oven-baked (17.78% total fatty acids) and steamed (21.1% total fatty acids) samples 
when compared with the control (15.9% total fatty acids) sample (Bastias et al., 2017).  
The effect of using two different cooking oils (extra virgin olive oil and sunflower oil) 










∑EPA ∑DHA Reference 
Oven-
Baked 
















28.40 14.60 8.1 54.6 16.9 1.8 25.5 3.4 5.8 Al-Saighir et 
al. 2004 
Steamed 31.44 21.20 10.34 42.30 26.08 2.04 33.45 7.46 10.85 Bastias et 
al. 2017 
Steamed 28.25 16.50 11.44 44.55 27.19 1.42 32.35 5.61 7.1 Larsen et al. 
2010 
Steamed 27.49 14.20 11.99 39.79 17.58 1.18 30.85 4.66 5.70 Sengor et 
al. 2014 




olive oil led to a higher fat absorption rate than sunflower oil. No significant difference 
was observed in the lipid profile of the farmed salmon. Frying in extra virgin olive oil, 
slightly increased oleic acid (from 27.59g/100g to 30.37g/100g fatty acids).  The n-6/n-
3 ratio increased from 0.38 (raw) to 0.39-0.58 in the pan-fried salmon. The quantity of 
EPA+DHA decreased slightly but no significantly in the pan-fried sample (Ansorena et 
al., 2010).  
Sengor et al., (2013) reviewed the effects of different cooking methods (baking, 
steaming and grilling) on the fatty acid composition on Atlantic salmon (Salmo salar) 
and reported no significant change (p > 0.05) in the various cooking methods when 
compared to the control (raw salmon). There was a significant difference in the 
cholesterol content (p<0.05) of the cooked salmon. EPA and DHA, the essential n-3 
PUFAs, increased in the grilled and oven-baked salmon samples. Gladyshev et al., 
(2006) concluded that thermal treatment (boiling, frying or grilling) generally did not 
affect the EPA and DHA content in humpback salmon, with the exception of a slight 
reduction when pan-fried. ∑n-3 PUFA content decreased in steam cooked and oven-
baked samples, whilst ∑n-3 PUFA content decreased in the steamed sample only.   
Similar findings were reported upon the analysis of grilled salmon, steamed and roasted 
salmon when compared to raw salmon. Differences were due to the fat variations 
observed using different thermal treatments. The highest fatty acid content was 
observed in the grilled salmon (Costa et al., 2015).  
Al-Saighir et al., (2004) examined the effect of different cooking procedures on lipid 
quality and cholesterol oxidation of farmed salmon fish (Salmo salar). The changes in 
the fatty acid content after the thermal treatments (pan-fried without oil, with olive oil, 
with corn oil, with partially hydrogenated plant oil and steamed) were not significant, in 
particular with emphasis on EPA and DHA. Changes in the total amounts of SFA, 
MUFA and PUFA after thermal treatment were marginal upon comparison to the 
control sample. Insignificant increases were observed in the SFA content of the pan-
fried samples using different frying oils when compared to the raw salmon and the 
steamed salmon. The use of different frying oils was attributed to the changes of total 
MUFA and PUFA content. As a consequence of these results, it was hypothesised by 
Al-Saighir et al., (2004) that pan-frying does not have an influence on the high content 
of n-3 fatty acids significantly, but a detectable yet marginal exchange of fats occurs 
between the salmon sample and the pan-frying medium. The use of partially 
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hydrogenated plant oil, which initially contains 2.2% TFA, did not increase the TFA 
content of the treated samples. 
The effects of the oxidation process affecting fatty acids and cholesterol in fried and 
roasted salmon was examined. Salmon samples were fried using different oils (olive oil 
and soya oil) and roasted. No significant differences were observed in the fatty acid 
profile of the treated samples. DHA exhibited a significant increase when sample was 
roasted. Samples that were fried in olive oil exhibited higher contents of MUFAs than 
the samples fried in soya oil. All of the thermally treated samples displayed an increase 
in MUFA content when compared to the control samples. An increase in the n-6/n-3 
ratio was also observed. Roasted salmon exhibited the lowest n-3 content (Echarte et 
al., 2001). 
Different cooking methods did not significantly affect the concentration of PUFAs such 
as arachidonic acid, adrenic acid, EPA and DHA. Although salmon that was either 
baked or fried showed a significant change in some PUFA levels (Echarte et al., 2001) 
The principle fatty acids in salmon were palmitic, oleic, EPA and DHA. lauric, 
arachidic and behenic acid levels did not significantly change during frying or baking 
process. DHA showed a significant increase during roasting. Further observation 
concluded that unsaturated fatty acids which are prone to oxidation did not oxidise 
significantly (Echarte et al., 2001). A study on deep-frying fish concluded the lipid 
content of salmon was not significantly altered (Candela et al., 1998). Al-Saighir et al., 
2004 reported no significant differences in the total amount of SFA, MUFA and PUFA 
in pan-fried salmon with oil, pan-fried salmon without oil or steamed salmon. D. Larsen 
et al., 2010 reported no significant differences in % of DHA, EPA or DPA in poached, 
pan-fried, microwaved, oven-baked steamed salmon except for the deep- fried sample 
which had significantly lower levels of DHA, EPA and DPA when compared to the all 
other methods. This is presumably due to the absorption of fatty acids from the cooking 
oil. The proportions of linolenic acid and oleic acid increased and consequently reduced 
the proportions of the LC n-3 FAs. Omega-6 FA content was significantly higher in the 
deep-fried sample. Poached and microwaved salmon had the lowest amount of DHA, 
EPA and DPA. 
Changes to the MUFAs and the PUFAs levels was attributed to the different oils used in 
the various preparations. Pan-frying in different oils and frying in different oils 
marginally increased the SFA content as opposed to the initial raw salmon and steamed 
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salmon. Bastias et al.,2017 reported no significant differences in PUFA content for all 
heat treatments compared to the control. Omega-3 FA levels increased in steamed 
salmon compared to the control. Ansorena et al.,2010 concluded that frying with olive 
oil slightly increased oleic acid to 30.4% whereas frying with sunflower oil increased 
linoleic acid up to 11.6%. 
 
1.4.1 Emerging Cooking Techniques namely the sous-vide cooking 
process 
The modern-day consumer markets are showing a demand for high quality pre-cooked 
chilled ready-to-eat meals. Sous vide cookery is an emerging cooking technique which 
has been proven to produce chilled foods with an extended shelf-life of about 4 weeks 
when stored at the appropriate temperatures (1-5ºC) (Schellekens, 1996). Sous vide is a 
French term meaning “under vacuum” and the foodstuff is cooked using sous vide can 
be defined as “raw materials or raw materials with intermediate foods cooked using 
precise temperatures and times using heat-stable vacuumized pouches” (Schellekens, 
1996).  Sous vide is an emerging cooking technique having come to prominence in the 
1990s in due to its ability to extend the shelf life of minimally processed foods without 
affecting the nutritional content of the food stuff. Sous vide cookery differs from 
conventional cookery methods in two fundamental areas: the use of vacuum sealed heat 
stable pouches that contains the food stuff to be cooked and also the use of precise 
cooking temperatures. The use of vacuum sealing has several benefits including: heat is 
transferred efficiently from the water (or steam) to the food; the food stuffs shelf life is 
extended due to the elimination of contamination risk during storage; oxidation is 
prevented thus off-flavours are inhibited; food remains nutritious and flavourful since 
moisture and flavour volatiles are retained within the vacuum- sealed pouches used in 
the process and this also reduces aerobic bacterial growth (Baldwin, 2012).  During 
conventional cooking methods such as grilling and roasting, some reactions occur that 
can alter the nutritional value of food positively (enhancement of the digestibility 
through denaturation of proteins in the food) or negatively (alteration of the fatty acid 
composition, especially a decrease in PUFAs due to lipid oxidation and the loss of heat 
labile water or fat-soluble vitamins and minerals. Consequently, some harmful chemical 
compounds are produced during cooking of protein-rich food such as fish. Among these 
chemical compounds, heterocyclic aromatic amines (HCA) have attracted significant 
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attention over the past decade. Several epidemiological studies have demonstrated a 
positive correlation between fish and meat consumption and several forms of cancer 
(Lichtenstein et al., 2006).  HCAs generally occur when protein-rich foods such as fish 
and meat are grilled or fried at high temperatures. It has been reported that most HCAs 
are mutagenic (Sugimura et al., 2004),  and in 1993, the International Agency for 
Research on Cancer concluded that almost all HCAs were carcinogenic. Sous-vide 
cooking possesses advantages over other conventional cooking methods due to the 
relatively mild cooking temperatures required.  
Lipids in fish and seafood tend to undergo oxidation quite easily due to the abundance 
of PUFA present. This lipid oxidation significantly lowers the nutrition and 
acceptability of the products (Cropotova et al., 2019b). The sous vide cooking process 
consists of lower heating temperatures and longer cooking times compared to 
conventional cooking methods which is followed by the rapid cool down to 
temperatures between 0-4ºC and chilled storage. This process is beneficial to obtaining 
the flavour of the food product and also improve the nutritional, texture and palatability 
characteristics (Cropotova et al., 2019a, Cropotova et al., 2019b). 
A study performed to exhibit the  effects of boiling, steaming and the sous-vide cooking 
process on the lipid and volatile profile of fish was carried out,  and especially the 
European sea bass (Dicentrarchus labrax) and it was reported  that none of the above 
cooking processes effected the sea bass lipids, including vitamin A, cholesterol and 
phospholipids. Steaming and the sous-vide process actually enriched the sea bass 
headspace (Nieva-Echevarria et al., 2017). 
 
1.4.2 Benefits of Sous-vide processing 
As previously mentioned, sous vide processing present advantages from both a 
technological and sensory analysis point of view. Regarding the technological aspect, 
sous vide provides a very efficient and consistent transfer of heat from water to food 
product. This efficiency allows for a greater degree of reproducibility in the process. 
The sous-vide process has been shown to increase the shelf life of products due to the 
absence of oxygen in the vacuum sealed pouches, therefore inhibition of lipid oxidation 
occurs. From the sensory analysis point of view, the sous-vide process is beneficial as it 
conserves the food stuffs volatile compounds and due to the anaerobic environment of 
the foodstuff, oxidative deterioration is avoided which is widely regarded as the 
34 
 
principal cause of off-flavours and odours. The benefits of sous-vide from a human 
health perspective have been widely documented. The conservation of the nutritional 
value of the foodstuff is the principal health benefit that sous-vide cookery has when 
compared to conventional cooking methods such as boiling and frying. This 
phenomenon is due to the use of low cooking temperatures which in turn inhibit the loss 
of compounds such as vitamins and anti-oxidants through solubilisation and 
volatilisation (Baldwin, 2012, Iborra-Bernad et al., 2013, Kosewski et al., 2018). 
 
1.4.3 Negative aspects of sous-vide processing 
Whilst sous-vide processing has many positive attributes, the process gives rise to issues 
from a microbiological aspect. The anaerobic conditions within the sous vide pouches 
can lead to botulism if toxinogenic strains of Clostridium botulinum are present and the 
temperature abuse of foodstuff that contains the microorganism occurs (Schellekens, 
1996). Garcia- Linares et al., 2004 postulated that the three main factors that determined 
the microbiological safety of sous-vide processed foods are: 
 Intensity of heat treatment and duration 
 Temperature achieved by rate of cooling 
 Management of chilled storage of product (temperature and time duration) 
Generally sous-vide foods are not safeguarded by low pH or low water activity, and 
typically do not contain preservatives (GARCÍA-LINARES et al., 2004). Therefore, the 
microbiological safety of these foods depends on the mild heat treatment consolidated 
with effective refrigeration storage (Stringer and Metris, 2018). 
 
1.4.4 Sensory Analysis 
In order to assess the sensory attributes of each different sous-vide cooked salmon 
preparation, sensory analysis was carried out in St. Angela’s College in Sligo. Sensory 
science is rapidly developing new methodologies of profiling and sensory mapping 
which differs from the conventional profiling and also in the statistical analysis of the 
results. Multiple Factor Analysis (MFA) was the projective mapping or napping 
technique we used in this study to collect data regarding the sensory attributes of the 
sous-vide prepared salmon. Untrained panellists were used to locate the cooked salmon 
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in different dimensions, relative to the similarities and differences. MFA analyses 





1.4.5 AIM OF STUDY 
The aim of the present study was to evaluate the effects of sous vide cooking process on 
the bio-functionality, lipid profile and sensory properties of salmon in several cooking 
preparations based on different temperatures and brining applied. In order to achieve 
such a goal, the present study aimed to: 
 Extract bioactive lipids from salmon fillets that were cooked by the sous-vide 
technique in different temperatures and brining cooking conditions, and 
appropriately separate/fractionate and further analyse these lipids. 
 Evaluate the anti-thrombotic bioactivities of the extracted bioactive lipids of 
sous vide cooked salmon fillets against human platelet aggregation induced by 
inflammatory and thrombotic mediators such as PAF and thrombin, but also by 
well-established platelet agonists such as collagen and ADP 
 Determine by LC-MS analysis the fatty acid composition of the bioactive TPL 
extracts from the sous vide cooked salmon fillets  
 Perform a Sensory analysis to determine consumer perception of the varying 





Materials and methods 
2.1 Chemicals and Reagents 
All plastic and glass consumables, reagents, and solvents were of analytical grade and 
were purchased from Fischer Scientific Ltd. (Dublin, Ireland). Evacuated sodium citrate 
S-monovettes and 20G safety needles for blood sampling were purchased from Sarstedt 
Ltd (Wexford, Ireland).  The platelet aggregation bioassay was carried out on a 
Chronolog-490 two-channel turbidimetric platelet aggregometer (Havertown, PA, 
USA), coupled to the accompanying AGGRO/LINK software package. All platelet 
aggregation consumables were purchased from Labmedics LLP (Abingdon on 
Thames,UK).Standard PAF,  thrombin ,  and Bovine Serum Albumin (BSA) were 
purchased from Sigma Aldrich (Wicklow, Ireland), while collagen and ADP were from 
CHRONOLOG (Havertown, PA, USA). All platelet aggregation consumables were 
purchased from Labmedics LLP (Abingdon on Thames, UK). Standard PAF, thrombin, 
egg phospholipid extract, and BSA were purchased from Sigma Aldrich (Wicklow, 
Ireland). Centrifugations were carried out on an Eppendorf 5702R centrifuge 
(Eppendorf Ltd., Stevenage, UK). Spectrophotometric analysis was carried out on a 
Shimadzu UV-1800 spectrophotometer (Kyoto, Japan). All salmon samples were placed 
in vacuum pouches and a Multivac Vacuum machine (Sepp Haggenmuller GmBh, 
Germany) was used. The salmon samples were cooked in a Grant JB Nova water bath 
(Grant Instruments, Cambridge, UK). 
2.2 Sous-vide process 
All salmon (Irish organic farmed salmon (Salmo salar) samples (fillets & heads) were    
provided by Marine Harvest (Co. Donegal, Ireland). All fish were reared in a natural 
environment ensuring that the fish possessed good body shape and sufficient muscle 
tone. The salmon samples provided were from the same provider (Marine Harvest) in 
specific conditions that are not altered throughout year. 
More specifically, Irish organic farmed salmon was produced by Marine Harvest at their 
farming facility in Co.Donegal, Ireland, with a diet containing only organic approved 
natural ingredients from sustainable sources with fish meal and oil derived from the 
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trimmings of fish caught for human consumption. All salmon fillets tested were 
harvested from thus farmed salmon of the same batch and LOT number. It should be 
noted that Marine Harvest have more than one cage to farm salmon simultaneously. 
Therefore, from the same cage of farmed salmon (1st batch), I was provided with raw 
salmon fillets to be used for first in line experiments. From the second cage of farmed 
salmon (2nd batch), I was provided again with salmon fillets to be used for the 2nd line of 
experiments. Therefore, these second line experiments were conducted in salmon 
samples of the same batch of fish but from a different cage of farming than the first in 
line experiments. Similar procedure was carried out for being provided of all salmon 
samples tested (n=22 in total) that were farmed at the same time (same LOT number). 
All the above were carried out several times within the same LOT number to ensure 
experimental reproducibility/repeatability, and thus the observed differences in 
bioactivities are related to the differences in experimental procedures (i.e. due to the 
various sous vide cooking temperatures and conditions) rather than the farming 
conditions and seasonal variability of the salmon. 
Salmon fillets were prepared in approximately 50g portions. A 10% sodium chloride to 
water solution was created.  Various sous vide cooking temperatures (52°C, 65°C and 
80°C) were used and for each different temperature a sample was either brined or un-
brined. After the sous-vide cooking process, the cooked salmon fillet was homogenised 
into organic solvents in accordance with the Bligh & Dyer method of lipid extraction 
(Bligh and Dyer, 1959) 
 
Figure 2.1: The sous-vide cooking process using brined/un-brined salmon fillets and 
various cooking temperatures. Salmon fillets were portioned into approximately 50g 
portions. Samples were either brined or un-brined. Samples were then placed into sous-
vide pouches and placed in vacuum chamber. Samples were placed in water bath set at 




Figure 2.2.  Flow Chart for the extraction, fractionation, analysis and evaluation of the bioactivities of lipid extracts derived from several 




2.3 Extraction and separation of bioactive polar lipid compounds from 
cooked salmon 
Three different sous vide cooking temperatures were used (52°C, 65°C & 80°C) and 
samples were either brined (10% sodium chloride in water) or un-brined.  
Several (n=22) 50-60g of each sous vide cooked salmon samples was homogenised 
mechanically using a Waring blender (Fisher Scientific Ltd)  and its total lipids (TL) 
were extracted into chloroform according to the method of (Bligh and Dyer, 1959) and 
flash vaporised under N2 stream, weighed, re-dissolved in 2mL of CHCl3/MeOH 1:1 
v/v, and stored at -20°C. For each sample, approximately 1/10 of the TL was stored in 
sealed vials at -20°C, whilst the remainder of TL was further separated into total neutral 
lipids (TNL) fraction and the total polar lipids (TPL) fraction using the counter-current 
distribution method developed by Galanos and Kapoulas, 1962. The TPL and TNL 
recovered from this method for each sous vide salmon preparation were weighed and 
stored for further analysis under a nitrogen stream at -20°C. 
 
 
Figure 2.3. Diagram demonstrating the counter-current distribution method.  
The TL was dissolved in 30ml of 87% pre-equilibrated ethanol solution and added to the 
first separation funnel containing 90ml of pre-equilibrated petroleum ether. After each 
addition to the separatory funnel, the funnel was shaken well to ensure the maximum 
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interaction of lipids with the solvents. Once phase separation occurs, the lower phase was 
transferred to the second separatory funnel, shaken well and the lower phase containing 
the TPL was extracted to a round-bottom flask. This process was repeated 8 times until 
all the TL had been washed through leaving the TNL in both separatory funnels dissolved 
in petroleum ether (P.E) which was extracted to a separate round-bottom flask and the 
TPL in other round bottomed flask 
2.4 Platelet aggregometry bioassay 
Blood collection from several healthy donors (n=12) and preparation of human platelet-
rich plasma (hPRP) was conducted as previously described (Tsoupras et al., 2019d).  
The Ethics Committee of the University of Limerick approved the protocol, which was 
performed in accordance with the Declaration of Helsinki. Healthy donors were fully 
aware that their blood samples were used in our study and written consent was 
provided. Briefly, the blood samples were collected from each donor by a specialised 
phlebotomist using sodium citrate anticoagulant (0.106 mol/L in a 1:10 ratio of citrate 
to blood; Sarstedt Ltd., Wexford, Ireland) and centrifuged at 194×g for 18minutes at 
24◦C with no brake applied. The supernatant hPRP was then transferred to 
polypropylene tubes at room temperature for the aggregation bioassays, whereas 
platelet-poor plasma (PPP) was obtained by further centrifuging the remainder of the 
blood specimens at 1465×g for 20 minutes at 24 ◦C with no brake applied. hPRP was 
adjusted to 500,000 platelets /µL if required by addition of the respective volume of 
PPP according to the absorbance of the hPRP measured using a spectrophotometer at 
530 nm (Shimadzu UV-1800, Kyoto, Japan). Aliquots of standard PAF stock solution in 
chloroform/methanol (1:1 v/v) were evaporated under a stream of nitrogen and re-
dissolved in BSA (2.5mgBSA/mLsaline) to obtain PAF solutions with final 
concentrations in the aggregometer cuvette ranging from 0.26 nM to 0.26 µM. The 
examined salmon PL samples were also dissolved in BSA (2.5 mg BSA/mL saline). 
Standard stock solutions of active thrombin, collagen, and ADP dissolved in saline were 
further diluted in saline prior testing. Then, 250 µL of PRP was added to an 
aggregometer cuvette at 37◦C with stirring at 1000 rpm. The PRP was calibrated using 
the PPP as a blank. The maximum-reversible platelet aggregation curve induced by  
PAF,  thrombin, collagen or ADP  was determined as 100% aggregation ,which was 
also used as a baseline (0% inhibition) in the absence of any lipid sample, by adding the 
appropriate amounts of each platelet agonist in the aggregometer cuvette , in order to 
reach specific final concentrations:  for PAF approximately 0.1–1 nM, for thrombin 
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approximately 0.01–0.4 U/mL, for collagen approximately 1–5 µg/mL and for ADP at 
approximately 2–10 µM. The PAF, thrombin, collagen, and ADP-induced aggregation 
of hPRP was calculated first at 0% inhibition of baseline in a cuvette (100% 
aggregation) in the absence of any lipid sample, whereas after the pre-incubation of 
hPRP with several amounts (µg) of the lipid samples in a diff erent cuvette for 2 min, 
the same amount of PAF, thrombin, collagen, or ADP that induced maximum-reversible 
platelet aggregation was added and the reduced aggregation was calculated. Thus, a 
linear curve at the 20%–80% range of the percentage of inhibition against PAF, 
thrombin, collagen, and ADP-induced aggregation of hPRP was deduced for each 
sample. From this curve, the concentration (µg) of the lipid sample that led to 50% of 
agonist-induced aggregation of hPRP was calculated as the 50% inhibitory 
concentration value also known as the IC50 value (half-maximal inhibitory 
concentration) for each sample. The resulting IC50 values were expressed as a mean 
value of the mass of lipid (µg) in the aggregometer cuvette ± standard deviation (SD). 
All experiments were performed several times (n≥10), using a diff erent donors’ blood 
samples for each replicate to ensure reproducibility. 
 
Figure 2.4. Flow diagram of the light transmission aggregometry technique for the 
evaluation and the monitoring of platelet defects and the effects of platelet aggregation 
agonists and antiplatelet compounds. Reproduced with modifications after permission 




2.5  LC-MS analysis 
The salmon TL and TPL fractions were analysed by LC-MS in Limerick Institute of 
Technology. Each of these lipids were separated into two vials and dried under nitrogen 
stream. The first vial was subjected to saponification with the addition of 1.5mL of 
saponification reagent, [2.5 M KOH: methanol (1:4, v/v)], then vortexed. The vials were 
then incubated at 72°C for 15 minutes before the addition of 225µL of formic acid. 
1725µL of chloroform and 375µL of Milli-Q water were added and vortexed. A 
biphasic separation was observed. The chloroform layer containing the free fatty acids 
was then transferred to amber vials and evaporated to dryness before storing at -20°C 
until LC-MS analysis took place.  
Before LC-MS analysis took place, all the dried lipids were re-constituted in 500 µL of 
methanol: dichloromethane (2:1 v/v), centrifuged at 13,000 rpm for 6 minutes prior to 
filtering through 3 kDa ultra-centrifuge filters (Amicon Ultra 3k). Polar lipid and free 
fatty acid profiles were obtained in a LC (Agilent 1260 series) equipped with a Q-TOF 
mass spectrometer (Agilent 6520) and the source type was ESI. The column used for 
separations was an Agilent C18 Poroshell 120 column (2.7 µm, 3.0 x 150mm). The 
composition of the mobile phase (A) was 2 mM ammonium acetate in water and 2 mM 
ammonium acetate in 95% acetonitrile for mobile phase (B). Chromatographic 
separation was performed by gradient elution starting with 60% B for 1 minute, then 
increasing to 90% B over 2.5 minutes. Then, 90% B was held for 1.5 minutes and 
increased afterwards to 100% over 5 minutes. Subsequently, 100% B was held for 4 
minutes, reducing afterwards to 60% B over 0.5 minutes and held for 1 minute until the 
next run. The mobile phase flow rate was 0.3 mL/minute until 5 minutes elapsed, 
increasing up to 0.6 mL/minute after 10 minutes and held at this flow rate until the end 
of the run. The injection volume was 10 µL. The mass spectrometer was operated in 
negative ionisation mode, scanning the lipids from m/z 50-1100. Drying gas flow rate, 
temperature, and nebuliser pressure were at 5 L min-1 , 325°C, and 30 psi, respectively. 
Fragmentor and skimmer voltages were kept at 175V and 65V, respectively, and the 
capillary voltage was 3500 V. In the negative ion mode, the monitoring reference 
masses used were 1033.988 and 112.9855, respectively. Assignment of free fatty acids 
and phospholipids species is based upon a combination of survey, daughter, precursor, 
and neutral loss scans. The identity of phospholipid species were verified using the 
LIPID MAPS: Nature Lipidomics Gateway (www.lipidmaps.org) , by using the lowest 




2.6  Sensory Analysis 
Descriptive sensory profiling is a method commonly used to identify the key sensory 
drivers in product development and reformulation in order to access consumer 
acceptance and the marketing of such products. Fast descriptive sensory profiling 
techniques such as Napping and CATA are frequently used in the food industry to 
assess the sensory aspects of products. Napping is a method where the food products are 
projected onto a two-dimensional space which is based on how similar the sensory 
aspects of each food product are in relation to each other. “Global” napping (including 
all sensory aspects) or “partial” napping (focusing on specific sensory aspects e.g. 
texture, smell or taste) are the most frequently used napping methods used in sensory 
analysis presently. Napping provides a rapid snapshot of a group of samples using all 
data from the assessors to create a consensus image. Once the panel provide the 2 D 
data, the results are further analysed to create multiple dimensions similar to Principal 
Component Analysis (PCA) plots, which are usually viewed two dimensions at a time. 
The results generated from napping can then be correlated to PCA plots generated from 
descriptive analysis. These two methods give similar results, as assessed by a 
multivariate correlation coefficient called the RV coefficient. The Check-all-that-apply 
(CATA) method in sensory analysis focuses on describing a product using appropriate 
selected descriptive words from a given list (Dehlholm et al., 2012). It evaluates 
sensory and non-sensory perception of products and has been shown to be in agreement 
with traditional panel-developed sensory profiles. The methodologies used to capture 
consumer perceptions of products are relatively less time consuming and generally 
easier to conduct than using the traditional descriptive analysis approach which uses a 
trained sensory panel. CATA participants are given a list of terms and asked to endorse 
those that characterise the sample (Bennett and Hayes, 2012). These questions are often 
used in market research to reduce the response burden of participants (Raginski et al., 
1994) as participants do not have to generate their own descriptors for each sample. 
CATA and napping were suitable sensory analysis techniques used in this thesis due to  
 Only one sensory analysis session was required 
 Less expensive to run than other descriptive analysis approaches 
 Doesn’t require expert sensory assessors 
 Assessors evaluate samples based on what is important to them 
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 Data from analysis can be acquired quickly using computers with sensory 
software 
 Gives an overall snapshot of samples 
Six salmon samples and a replicate (control Brined 80oC) were all tested by 30 
assessors using napping followed by check-all-that apply. Tests were conducted in 
designated individual booths under artificial daylight. 30 assessors (age 18-60, 19 
female) with experience in sensory evaluation but no previous experience in napping 
evaluated the products. The assessors were asked to provide information in relation to 
consumption of salmon (40% would consume salmon weekly, 27% monthly and the rest 
occasionally) and the majority of them would consume it baked (42%) or smoked 
(31%). This study does not rely on subjective measurement of the salmon samples but 
objective measurements of the attributes. Therefore, the frequency of consumption does 
not affect the final sensory results. In other words, the assessors were not asked to 
express preference or liking which would be affected by the frequency of consumption.   
 For the napping test they were given instructions in the beginning of the test  
“Please taste all the samples, in the order presented to you.  Place the samples by 
dragging the code across into the rectangle according to the strategy that two samples 
placed closer to each other are more alike than two samples placed further apart. The 
criteria for how to separate the samples just has to make sense to you. There is no 
right or wrong answer.”.  
Furthermore, a scientist was present during the testing in order to answer the assessors’ 
questions.  The seven salmon samples (six samples and the replicate) were 
simultaneously presented in a random order to each assessor.  Random order was used 
in order to counter-act first order and carry-over effects, despite the fact that assessors 
were allowed to re-taste the samples (Reinbach et al., 2014).  
The assessors were requested to taste the samples and to lay them out on in a 
rectangular space on the screen in such a way that two salmon samples were very near if 
they seemed similar and that two salmon samples were distant from one another if they 
seemed different. For each salmon product, both X co-ordinate and Y co-ordinate were 
collected through Fizz Biosciences software. Assessors were also asked to give reasons 





The next stage of testing included a check-all-that-apply (CATA) test were the 
participants were asked to check a number of terms for each of the samples they were 
presented. The 17 attribute terms used for the CATA session (Appearance (A)- 
pink/salmon, discoloured, fatty/oily; Odour (O)- strong fishy, mild fishy; Texture (Tx)- 
soft, firm, dry, moist, flaky; Taste (T)- sweet, salty, umami and Aftertaste (At) – strong 
fishy, mouth drying, oily and sweet)  were developed during a vocabulary session with 
untrained participants, where all six samples (without the replicate) were presented 
monadically to the panellists and they were asked to write down as many terms as 
possible in relation to the appearance (A), texture (Tx), taste (T), odour (O) and 
aftertaste (AT) of the samples.  
2.7 Statistical Analysis 
All experiments were completed in triplicate with the obtained results expressed as a 
mean value ± standard deviation (SD). These values were obtained using one-way 
analysis of variance (ANOVA) and the Kruskal-Wallis non-parametric test to determine 
significant statistical differences between analyses if present for all data except for the 
analyses of the LC-MS data where one-way analysis of variance (ANOVA) and the 
Tukey’s honest significant difference (HSD) multiple comparison post-hoc test was used 
(SPSS Inc., Chicago, 215 IL, USA). 
The analysis of data from sensory evaluation included analysis of the napping data and 
data from check-all-that-apply. For the data generated from napping, Multiple Factor 
Analysis as described by other researchers (Le Dien and Pagès, 2003) was used to 
generate the bi-plots of the products using XL Stat  software. Factomine-R software was 
used to generate the factor map/score with confidence ellipses as described by Christian 
Dehlholm 2014 (in Novel techniques in Sensory Characterisation and Consumer 
Profiling by P. Varela and G. Ares (2014). Although CATA results are usually 
considered exploratory or descriptive (Fleming et al., 2013) for this study CATA data 
were analysed using a Cochran’s Q test in order to find differences between samples. 
This was conducted using XLStat and the symmetric plots were generated. Pairwise 





3.1 Yield of extraction and separation of bioactive lipids from 
cooked salmon 
Total lipids (TL) of all salmon samples (n=22) were extracted and separated into total 
polar lipids (TPL) and total neutral lipids (TNL). The recovered amounts of TL, TPL 
and TNL (expressed as g of lipids/100g of fish tissue) are given in Table 3.1. The 
majority of the lipids that were extracted were of neutral lipid nature which is agreement 
with the literature (Tsoupras et al., 2018a). The neutral lipid fraction of raw salmon 
fillets generally comprises of approximately 60-84% of the TL, whilst the total polar 
fraction contributes to approximately 16-40% of the TL (Tsoupras et al., 2018a). 
The TL was extracted in triplicate (n=3) from six separate samples of the salmon using 
several sous-vide cooking procedures. The TL of these samples was further separated to 
TPL and TNL. These results are displayed on Table 3.1 expressed as g of lipids per 100g 
of sample, with the TPL and TNL also being displayed as a percentage of the TL. 
The content for total lipids (TLs), neutral lipids (NLs) and PLs is presented in Table 3.1 
and is expressed as g per 100 g of fish tissue for all samples. Salmon is generally 
categorised as oily fish species, thus their lipid content is usually higher than other fish 
species. In this present study also, all salmon samples had high lipid content as reflected 
by their TLs, which is in accordance with the literature (Tsoupras et al., 2018a).  
Interestingly, the cooking of all sous vide salmon preparations yielded similar values for 
TL when compared to that of TL from raw salmon as reported by (Tsoupras et al., 2018a).  
Moreover, all samples exhibited higher levels of TNL when compared to the raw salmon 
samples 
The 52°CSVSB contained significantly less amounts of TPL when compared to all other 
salmon preparations. The effect of brining exhibited no differences in the yield of 
extraction in TL, TNL and TPL. 
Tsoupras et al., 2018a reported that the majority of lipids extracted from raw salmon 
fillets were neutral lipids (NLs) since NLs contribute to approximately 60-84% of the TL 
of raw salmon, thereby the TPL fraction of the raw salmon fillets comprises of 
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approximately 16-40% of the TL. Notably, the % TNL of all sous-vide cooked salmon 
samples exhibited higher % of TNL. Interestingly, all of the sous-vide cooked salmon 
samples displayed lower % TPL. 
The Bligh & Dyer method of extraction is one of the most well-established methods for 
high yield of extraction of lipids in combination with the high stability of key bioactive 
lipid substances extracted, since it does not need heat treatment. In contrast, other well- 
established techniques (such as the Soxhlet method), even though they may well exhibit 
higher yields of extraction, because they are applying higher temperatures, there is an 
increased possibility of modifications in both structures and relative bioactivities of these 
key substances. Within this study, we chose to use the Bligh & Dyer method of extraction 
and the subsequent Galanos & Kapoulas counter current distribution for extracting the 
bioactive polar lipids of salmon, since they have been tested effectively in several marine 
sources including salmon, with high yield of bioactive polar lipids (Tsoupras et al., 2018a, 
Panayiotou et al., 2000, Nasopoulou et al., 2014). By applying this experimental 
approach, almost all of the PL fraction was recovered from salmon in accordance with 















Table 3.1. The Total lipid (TL), total neutral lipid (TNL) and total polar lipid (TPL) 
expressed as g/100g of sample with TNL and TPL also being expressed as a percentage 
of TL (range values, n=3) 








RSF 3.61-7.41 2.58-6.74 60-84 0.50-1.22   16-40 
52°CSVSNB 4.81-8.73 4.21-8.01 85.59-90.47 0.49-0.83 9.54-14.42 
52°CSVSB 5.87-8.21 5.09-7.35 86.82-92.86 0.74-0.92 7.14-13.18 
65°CSVSNB 7.27-7.61 6.54-6.84 89.24-90.74 0.69-0.79 9.25-10.75 


















 Abbreviations: RSF = raw salmon fillets; 52CSVSNB = 52°C sous-vide cooked salmon 
no brine; 52CSVSB = 52°C sous-vide cooked salmon brined; 65CSVSNB = 65°C sous-
vide cooked salmon no brine; 65CSVSB = 65°C sous-vide cooked salmon brined; 
80CSVSNB = 80°C sous-vide cooked salmon no brine; 80CSVSB = 80°C sous-vide 
cooked salmon brined 
 
3.2 The effect of several sous-vide cooking preparations on the bio-
functionality of salmon lipids against platelet aggregation 
The effect of several sous-vide cooking preparations on the bio-functionality of salmon 
lipids against platelet aggregation induced by inflammatory and thrombotic mediators 
such as PAF and thrombin, but also by well-established platelet agonists, such as 
collagen and ADP, is presented in Appendix II, in relation to raw salmon fillets 
(Tsoupras et al., 2019c) and unpublished data communicated  from Dr. Alexandros. 
Tsoupras 2019.  
The in vitro antithrombotic activities of TPLs from sous-vide processed salmon using 
different cooking procedures was evaluated for the first time by their inhibitory effects 
against human platelet aggregation induced by PAF, thrombin, collagen, and ADP. 
These effects were expressed by their IC50 values (half-maximal inhibitory 
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concentrations) against each platelet agonist. The absolute results for these IC50 values 
are shown in Appendix II. It should be noted that the lower the IC50 value the stronger 
the inhibition against the platelet agonist tested. 
The IC50 values obtained against platelet aggregation, induced by all these platelet 
agonists, showed that all of the TPL extracts exhibited strong antithrombotic effects. 
More specifically, apart from the TPLs derived from the 80°CSVSNB and the 
80°CSVSB sous vide salmon preparations, TPLs from the other sous vide salmon 
preparations strongly inhibited the PAF pathway of platelet aggregation. These anti-
PAF effects of the TPLs from 52°CSVSNB, 52°CSVSB,  65°CSVSNB and 65°CSVSB 
sous vide salmon preparations were found within the same range whilst remaining 
similar to that previously reported anti-PAF effects of the TPL extracts of raw SFS as 
reported by (Tsoupras et al., 2019c)  (p > 0.05 in all these comparisons) and other raw 
marine sources (Nasopoulou et al., 2007, Panayiotou et al., 2000). On the other hand, 
the TPLs derived from sous vide salmon preparations using higher temperatures, 
namely the 80°CSVSNB and 80°CSVSB preparations, exhibited approximately the 
same anti-PAF effects, which however were significantly lower than the anti-PAF 
effects of all the other sous vide salmon preparations (p<0.05 in all comparisons). 
Moreover, the IC50 values of the anti-PAF effects of the TPLs derived from the 
80°CSVSNB and 80°CSVSB preparations were approximately one order of magnitude 
lower than those of the previously reported raw salmon fillets (Tsoupras et al., 2019c) 
(p<0.05 in all comparisons). 
The TPLs from the 52°CSVSNB, 52°CSVSB and 65°CSVSB exhibited the strongest 
inhibitory effects against thrombin-induced platelet aggregation in comparison to the 
TPLs extracted from all the other sous vide preparations in higher temperatures. These 
anti-thrombin effects were also found similar to previously reported anti-thrombin 
effects of the TPL extracts of raw SFS as reported by Tsoupras et al.2019 (p > 0.05 in 
all these comparisons). On the other hand the TPLs derived from sous vide salmon 
preparations using higher temperatures, namely the 80°CSVSNB and 80°CSVSB 
preparations, exhibited approximately the same anti-thrombin effects, which however 
were significantly lower than the anti-thrombin effects of all the other sous vide salmon 
preparations (p<0.05 in all comparisons) and from those of the previously reported raw 





Figure 3.1 Antithrombotic activities of TPL extracts from various salmon samples (raw 
and various sous-vide preparations) against platelet-activating factor (PAF)-induced 
aggregation of human platelets. Results are expressed as IC50 (half-maximal inhibitory 
concentration) values that reflect the inhibitory strength of each PL extract against PAF-
induced platelet aggregation and is expressed as mean values of μg of PLs in the 
aggregometer cuvette that causes 50% of inhibition of PAF-induced aggregation of 
platelets in human platelet-rich plasma (hPRP) ± SD. It should be noted that the lower the 
IC50 value, the stronger the inhibition against the platelet agonist tested. * Indicates 
statistically significant differences of the less bioactive extract (p < 0.05).   Abbreviations: 
TPL: Total Polar Lipids    Raw SF = raw salmon fillets; 52CSVSNB = 52°C sous-vide 
cooked salmon no brine; 52CSVSB = 52°C sous-vide cooked salmon brined; 65CSVSNB 
= 65°C sous-vide cooked salmon no brine; 65CSVSB = 65°C sous-vide cooked salmon 
brined; 80CSVSNB = 80°C sous-vide cooked salmon no brine; 80CSVSB = 80°C sous-
vide cooked salmon brined SD: standard deviation. 
Interestingly, the above mentioned anti-thrombin effects of the TPLs from all sous vide 
preparations were significantly lower than their relative anti-PAF effects, suggesting a 
higher specificity of these TPL against the PAF-pathway, rather than the thrombin 
pathway, in a similar pattern with the previously reported anti-PAF and anti-thrombin 
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activities of the TPL from raw salmon fillets, using the same extraction method and 
counter-current distribution method (Tsoupras et al., 2018a).  
 
Figure 3.2. Antithrombotic activities of TPL extracts from various salmon samples 
(raw and various sous-vide preparations) against thrombin-induced aggregation of human 
platelets. Results are expressed as IC50 (half-maximal inhibitory concentration) values 
that reflect the inhibitory strength of each PL extract against PAF-induced platelet 
aggregation and is expressed as mean values of μg of PLs in the aggregometer cuvette 
that causes 50% of inhibition of thrombin-induced aggregation of platelets in human 
platelet-rich plasma (hPRP) ± SD. It should be noted that the lower the IC50 value, the 
stronger the inhibition against the platelet agonist tested. # Indicates statistically 
significant differences of the less bioactive extract (p < 0.05).   Abbreviations: TPL: Total 
Polar Lipids    RSF = raw salmon fillets; 52CSVSNB = 52°C sous-vide cooked salmon 
no brine; 52CSVSB = 52°C sous-vide cooked salmon brined; 65CSVSNB = 65°C sous-
vide cooked salmon no brine; 65CSVSB = 65°C sous-vide cooked salmon brined; 
80CSVSNB = 80°C sous-vide cooked salmon no brine; 80CSVSB = 80°C sous-vide 




Figure 3.3 Antithrombotic activities of TPL extracts from various salmon samples (raw 
and various sous-vide preparations) against ADP-induced aggregation of human platelets. 
Results are expressed as IC50 (half-maximal inhibitory concentration) values that reflect 
the inhibitory strength of each PL extract against ADP-induced platelet aggregation and 
is expressed as mean values of μg of PLs in the aggregometer cuvette that causes 50% of 
inhibition of PAF-induced aggregation of platelets in human platelet-rich plasma (hPRP) 
± SD. It should be noted that the lower the IC50 value, the stronger the inhibition against 
the platelet agonist tested. # Indicates statistically significant differences of the less 
bioactive extract (p < 0.05).   Abbreviations: TPL: Total Polar Lipids    RSF = raw salmon 
fillets; 52CSVSNB = 52°C sous-vide cooked salmon no brine; 52CSVSB = 52°C sous-
vide cooked salmon brined; 65CSVSNB = 65°C sous-vide cooked salmon no brine; 
65CSVSB = 65°C sous-vide cooked salmon brined; 80CSVSNB = 80°C sous-vide 
cooked salmon no brine; 80CSVSB = 80°C sous-vide cooked salmon brined SD: standard 
deviation. 
 
Furthermore, the TPLs from sous vide preparations, the ones treated in low 
temperatures (52o-65oC), exhibited strong inhibitory effects against ADP-induced 
platelet aggregation, whilst their strong anti-ADP effects were similar with the anti-
ADP effects of TPLs from raw SF (Unpublished data communicated from Dr 
54 
 
Alexandros Tsoupras). Instead, the 80°CSVSNB and 80°CSVSB samples exhibited 
significantly lower anti-ADP effects from all the other sous vide preparations or even 
from raw SF (p<0.05 in all these comparisons).  
 
 
Figure 3.4. Antithrombotic activities of TPL extracts from various salmon samples 
(raw and various sous-vide preparations) against collagen-induced aggregation of human 
platelets. Results are expressed as IC50 (half-maximal inhibitory concentration) values 
that reflect the inhibitory strength of each PL extract against collagen-induced platelet 
aggregation and is expressed as mean values of μg of PLs in the aggregometer cuvette 
that causes 50% of inhibition of PAF-induced aggregation of platelets in human platelet-
rich plasma (hPRP) ± SD. It should be noted that the lower the IC50 value, the stronger 
the inhibition against the platelet agonist tested. # Indicates statistically significant 
differences of the less bioactive extract (p < 0.05).   Abbreviations: TPL: Total Polar 
Lipids    RSF = raw salmon fillets; 52CSVSNB = 52°C sous-vide cooked salmon no brine; 
52CSVSB = 52°C sous-vide cooked salmon brined; 65CSVSNB = 65°C sous-vide 
cooked salmon no brine; 65CSVSB = 65°C sous-vide cooked salmon brined; 80CSVSNB 
= 80°C sous-vide cooked salmon no brine; 80CSVSB = 80°C sous-vide cooked salmon 




Nevertheless, the anti-ADP effects of TPL form all sous vide preparations were stronger 
than their anti-thrombin and lower than their anti-PAF effects (p<0.05 in all these 
comparisons), respectively, apart from the TPL of both the 80°CSVSNB and 
80°CSVSB samples that had similar anti-ADP and anti-PAF effects (p>0.05 in all these 
comparisons) 
Differently than the effects of the TPL from sous vide preparations against all the other 
platelet agonists, the anti-collagen effects of the TPL from all sous vide preparations 
exhibited different pattern. More specifically, the TPLs from both 65°CSVSNB and 
65°CSVSB samples had the strongest inhibitory effects against collagen-induced 
platelet aggregation than all samples tested. The anti-collagen effect of these two sous 
vide preparations were significantly stronger not only when compared with the anti-
collagen effects of the TPL from 80°CSVSNB and 80°CSVSB, but also when compared 
with the anti-collagen effects of the TPL from 52°C sous vide salmon preparations and 
that of the raw salmon fillets (see Appendix II) ( Unpublished data communicated from 
Dr Alexandros Tsoupras ) (p<0.05 in all these comparisons). 
Interestingly, the anti-collagen effects of TPL from both 65°CSVSNB and 65°CSVSB 
samples were stronger from their anti-PAF, anti-ADP and anti-thrombin effects in these 
conditions applied. This suggests that both 65°CSVSNB and 65°CSVSB seem to 
contain TPL moieties with higher specificity against the collagen pathway than all the 
other samples. 
The in vitro antithrombotic activities of TPLs from Raw SH, 80°CSVSHNB and 
80°CSVSHB were evaluated by their inhibitory effects against human platelet 
aggregation induced by well renowned platelet agonists namely PAF, thrombin, 
collagen and ADP. These effects were expressed using IC50 values against each 
individual platelet agonist.  
The IC50 values obtained against platelet aggregation, induced by PAF, collagen and 
ADP, showed that all PL extracts possessed strong antithrombotic effects. 
For PAF, collagen ADP no difference was observed between cooked and raw (p>0.05 in 





Figure 3.5. Antithrombotic activities of TPL extracts from salmon heads against 
PAF/thrombin/ADP/collagen-induced aggregation of human platelets. Results are 
expressed as IC50 (half-maximal inhibitory concentration) values that reflect the 
inhibitory strength of each TPL extract against collagen-induced platelet aggregation 
and is expressed as mean values of μg of TPL in the aggregometer cuvette that causes 
50% of inhibition of collagen-induced aggregation of platelets in hPRP ± SD. It should 
be noted that the lower the IC50 value, the stronger the inhibition against the platelet 
agonist tested. * and # indicate statistically significant differences (p < 0.05) for the 
most and least bioactive extracts, respectively. Raw SH: raw salmon head; hPRP: 
human platelet-rich plasma; 80CSVSHNB = 80°C sous-vide cooked salmon head no 
brine; 80CSVSHB = 80°C sous-vide cooked salmon head brined 
 
3.2 The effect of several sous-vide cooking procedures on the fatty acid 
content and structures of bioactive salmon lipids. 
In order to evaluate the fatty acid composition of salmon TPL from all sous vide 
preparations, AS WELL AS TO GET INSIGHTS FOR THE ABOVE RESULTS TPL 
were saponified and analysed by LC-MS analysis. Representative chromatograms of 
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such an analysis for the saponified salmon TPL are shown in Figure 3.6.  In addition, 
the changes of the obtained fatty acid composition of salmon PLs from all sous vide 
preparations can be seen in Figure 3.7 (The absolute values for FA-content can be 
observed in APPENDIX III). It is clear that these PL samples were rich in PUFA and 
especially in ω3 PUFA with a low ratio of n-6/n-3. More specifically, in PLs from 
52°CSVSB, the SFA were the most abundant fatty acid class followed by the PUFA and 
monounsaturated fatty acids (MUFA) (). PLs from 52°CSVSB contain high amounts of 
ω3 PUFA, with the most abundant n-3 fatty acids being DHA (22:6ω3) and EPA 
(20:5ω3). Similar amounts of n-6 fatty acids were also present with the most abundant 
being linoleic acid (LA; 18:2ω6) followed by less amounts of DPA and arachidonic acid 
(ARA; 20:4ω6). Furthermore, the most abundant of the MUFA was found to be oleic 
acid (18:1 c9), followed by lower but considerable amounts of gadoleic acid (20:1 c9). 
In the SFA the most abundant was the palmitic (16:0), followed by lower but 
considerable amounts of stearic acid (18:0). The overall n-3 fatty acid content of the 
PLs from 52°CSVSB was similar to that of their n-6 fatty acids and thus the ratio of n-
6/n-3 in PLs from 52°CSVSB was approximately 0.95. 
Similarly, in the 52°CSVSNB PLs the SFA were the most abundant fatty acid class 
followed by PUFA and MUFA (Appendix II). PLs from 52°CSVSNB contain high 
amounts of n-3 PUFA, with the most abundant n-3 fatty acids being EPA (20:5ω3), 
while considerable but less amounts of DHA (22:6ω3) were also present. Considerable 
amounts of ω6 fatty acids were also present with the most abundant being linoleic acid 
(LA; 18:2ω6) followed by less amounts of arachidonic acid (ARA; 20:4ω6). Moreover, 
the most abundant of the MUFAs was found to be oleic acid (18:1 c9) and followed by 
gadoleic acid (20:1 c9). Palmitic acid (16:0) was deemed to be the most prevalent SFA 
followed by stearic acid (18:0). The overall ω3 fatty acid content of 52°CSVSNB was 
similar to that of n-6 fatty acids and thus the ratio of n-6/n-3 was found to be 
approximately 1.03 (Appendix II) 
Similarly, in the PLs 65°CSVSB the SFA were the most abundant fatty acid class 
followed by the PUFA and less amounts of the MUFA (Appendix II). PLs from 
65°CSVSB contained high amounts of n-3 PUFA, while the most abundant n-3 fatty 
acid present being DHA (22:6ω3) followed by EPA (20:5ω3), while considerably less 





Figure 3.6.  Representative chromatograms of the LC-Ms analysis of the saponified 
salmon TPL from all sous vide preparations. A1 represents salmon cooked using the 
sous vide process at 52°C brined, A2 represents salmon cooked using the sous vide 
process at 52°C un- brined. B1 represents salmon cooked using the sous vide process at 
65°C brined, B2 represents salmon cooked using the sous vide process at 65°C un-
brined, C1 represents salmon cooked using the sous vide process at 80°C brined, C2 




Figure 3.7. Depicts the FFA composition of the sous vide salmon preparations, using 
different cooking temperatures and conditions, fractions acquired by LC-MS analysis 
after saponification of these samples. 52CSVSNB = 52°C sous-vide cooked salmon no 
brine; 52CSVSB = 52°C sous-vide cooked salmon brined; 65CSVSNB = 65°C sous-
vide cooked salmon no brine; 65CSVSB = 65°C sous-vide cooked salmon brined; 
80CSVSNB = 80°C sous-vide cooked salmon no brine; 80CSVSB = 80°C sous-vide 
cooked salmon brined. 
60 
 
Considerable amounts of n-6 fatty acids were also present with the most prevalent being 
linoleic acid (LA; 18:2ω6) followed by considerably less amounts of arachidonic acid 
(ARA; 20:4ω6). Notably, similar to the PLs of 52°CSVSNB, the overall n-3 fatty acid 
content of the PL from 65°CSVSB was similar to that of the n-6 fatty acids and 
therefore the ratio of n-6/nn-3 was found to be approximately 1.04. In addition, the most 
abundant of the MUFA in PL from 65°CSVSB was deemed to be oleic acid (18:1 c9) 
followed by gadoleic acid (20:1c9) and in the SFA the palmitic acid (16:0) and the 
stearic acid (18:0). 
Similar to that of the previous samples, SFA was the most abundant fatty acid class 
followed by PUFA and MUFA. The majority of the PUFA contained in the PLs from 
65°CSVSNB was found to be n-6 fatty acids, with the most abundant being linoleic acid 
(LA; 18:2ω6) and arachidonic acid (ARA; 20:4ω6). The most abundant n-3 fatty acids 
being DHA (22:6ω3) followed by considerably lower amounts of EPA (20:5ω3) 
(Appendix II). Notably, due to the higher overall n-6 fatty acid content in comparison to 
the n-3 fatty acids, the ratio of n-6/n-3 was found to be approximately 1.63 which is 
highest of the n-6/n-3 ratios in this study. In addition, the most abundant of the MUFA 
in PL from 65°CSVSNB was found to be oleic acid (18:1c9) and gadoleic acid (20:1c9) 
and the SFA the palmitic acid (16:0) and the stearic acid (18:0). 
Following a similar trend, the PLs from 80°CSVSB exhibited SFA as the most abundant 
fatty acid class followed by PUFA and MUFA (Appendix II). The majority of the 
PUFA contained in PLs from 80°CSVSB were found to be n-6 PUFAs with the most 
abundant n-6 fatty acid being linoleic acid ((LA; 18:2ω6) and di-homo linoleic 
(20:2ω6). The most abundant n-3 fatty acids being DHA (22:6ω3) and EPA (20:5ω3). 
The overall the overall n-3 fatty acid content of the PL from 80°CSVSB were similar to 
that of the n-6 fatty acids and thus the ratio of n-6/n-3 was found to be approximately 
1.07. PLs from 80°CSVSB contained relatively high amounts of SFA with the most 
abundant being palmitic acid (16:0) followed by less, but considerable, amounts of 
stearic acid (18:0) and MUFA, with the most abundant of the MUFA being oleic acid 
(18:1 c9) and gadoleic acid (20:1c9). 
Finally, the SFA were the most abundant fatty acid class in the PL from 80°CSVSNB, 
followed by the PUFA and to a lesser extent the MUFA (Appendix II). The PUFA 
contained in the PL from 80°CSVSNB were mostly found to be n-6 PUFA with the 
majority being linoleic acid (LA; 18:2ω6). The most abundant n-3 fatty acids being 
DHA (22:6ω3) followed by lower amounts of EPA (20:5ω3). The n-6/n-3 ratio was 
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found to be approximately 1.19. PLs of 80°CSVSNB exhibited relatively high amounts 
of SFA with palmitic acid (16:0) followed by stearic acid (18:0) but also considerable 
amounts of MUFA with the most abundant being oleic acid (18:1c9) and gadoleic acid 
(20:1c9). 
3.4   Sensory Analysis 
 Data collected from napping were analysed using multiple factor analysis. As seen 
from the scree plot (supplementary data) the first two factors can explain the 57.10% of 
variance. As seen in Figure 3.8, factor 1 separates the sous vide samples at 52°C from 
the rest of the samples. Factor 3.9 separates the brined samples from the un-brined ones. 
The judges were asked to write down the attributes of the products which led to their 
groupings and it was found that 25 out of the 30 judges created their groups based on 
the texture of the products. Whereas only eleven times taste was mentioned and only 
one judge mentioned saltiness in specific. Seven times appearance was mentioned as a 
contributing factor for creating groups. Groupings generated from napping can be 
further explained in CATA data are taken into consideration. 
 
Figure 3.8: Principal coordinate analysis (PCA) plots from multiple factor 






























 The Figure 3.9 represents the symmetric plot of the products and the attributes as resulted 
from the principal coordinate analysis (PCA) of the CATA data. The first two dimensions 
explain 83.99% of the variation and the scree plot indicates the two first dimensions are 
sufficient to interpret the relationships between the attributes and the products. In this 
figure, it is observed that the two sous-vide samples at 52°C were perceived more similar 
and were characterised by attributes such as Fatty/Oily Appearance, Strong Fishy Odour, 
Moist Texture. Whereas the control samples and the samples sous-vide at 65°C were 
closer in the PCA plot and they were characterised as Flaky, Firm. This was expected 
since these samples were cooked at temperatures above 60oC. 
 
Figure 3.9: Symmetric plot of products as revealed from the principle coordinate 
analysis on the CATA data. Abbreviations: At: Aftertaste; Tx: Texture; O: Odour; A: 
Aroma; T: Taste; Sousvide 52: salmon cooked sous-vide @ 52°C no brine; Sousvide B 
52: salmon cooked sous-vide @ 52°C brined; Sousvide 65: salmon cooked sous-vide @ 
















































salmon cooked sous-vide @ 80°C no brine; Control B80: salmon cooked sous-vide @ 
80°C brined. 
Table 3.4: Proportion of 1s across assessors for each combination of products and 
attributes.  Multiple pairwise comparisons of products applying the McNemar test on the 
data from CATA. Abbreviations: A:Aroma; O:Odour; Tx:Texture; T:Taste; 
At:Aftertaste. 52CSVSNB = 52°C sous-vide cooked salmon no brine; 52CSVSB = 52°C 
sous-vide cooked salmon brined; 65CSVSNB = 65°C sous-vide cooked salmon no brine; 
65CSVSB = 65°C sous-vide cooked salmon brined; 80CSVSNB = 80°C sous-vide 
cooked salmon no brine; 80CSVSB = 80°C sous-vide cooked salmon brined. *values 
across the rows sharing the same letter do not differ significantly.  
 
In Table 3.4 shows the proportions of 1s across assessors for each combination of 
products and attributes. A high proportion means the attribute is frequently ticked by the 
judges for the product under investigation. For a given attribute, the Cochran’s Q test 
allowed to test for a given product whether the judges feel the attribute or not. For the 
cases of significant p- values multiple pairwise comparison where conducted by applying 
the McNemar test using XLstat 2018. Products with the same letter do not differ 
significantly. As seen on the table the main differences across samples are observed in 
Attributes p-values 52SVSNB 52SVS B 65SVSNB 65SVS B 80SVSNB 80SVSB 
A-Pink/Salmon 0.991 0.600 (a) 0.567 (a) 0.533 (a) 0.533 (a) 0.567 (a) 0.600 (a) 
A-Discoloured 0.290 0.200 (a) 0.100 (a) 0.200 (a) 0.267 (a) 0.100 (a) 0.233 (a) 
A-Fatty/Oily 0.000 0.633 (b) 0.500 (b) 0.200 (ab) 0.200 (ab) 0.067 (a) 0.233 (ab) 
O-Strong Fishy 0.342 0.300 (a) 0.233 (a) 0.167 (a) 0.100 (a) 0.100 (a) 0.167 (a) 
O-Mild Fishy 0.791 0.400 (a) 0.467 (a) 0.567 (a) 0.500 (a) 0.533 (a) 0.433 (a) 
Tx-Soft 0.000 0.567 (ab) 0.667 (b) 0.433 (ab) 0.367 (ab) 0.200(ab) 0.267 (ab) 
Tx-Firm 0.000 0.133 (ab) 0.033 (a) 0.533 (bc) 0.267 (abc) 0.600 (c) 0.567 (c) 
Tx-Dry 0.000 0.033 (a) 0.067 (ab) 0.200 (ab) 0.167 (ab) 0.500 (b) 0.233 (ab) 
Tx-Moist 0.001 0.767 (b) 0.667 (ab) 0.367 (ab) 0.533 (ab) 0.333 (a) 0.400 (ab) 
Tx-Flaky 0.060 0.100 (a) 0.100 (a) 0.300 (a) 0.300 (a) 0.133 (a) 0.300 (a) 
T-Sweet 0.498 0.133 (a) 0.067 (a) 0.067 (a) 0.133 (a) 0.167 (a) 0.033 (a) 
T-Salty 0.353 0.100 (a) 0.233 (a) 0.267 (a) 0.267 (a) 0.133 (a) 0.167 (a) 
T-Umami 0.714 0.200 (a) 0.200 (a) 0.100 (a) 0.200 (a) 0.200 (a) 0.233 (a) 
At-Strong Fishy 0.107 0.367 (a) 0.300 (a) 0.200 (a) 0.167 (a) 0.233 (a) 0.067 (a) 
At-Mouth Drying 0.000 0 (a) 0.067 (ab) 0.367 (ab) 0.133 (ab) 0.433 (b) 0.233 (ab) 
At-Oily 0.000 0.533 (b) 0.267 (ab) 0.100 (a) 0.233 (ab) 0.067 (a) 0.233 (ab) 
At-Sweet 0.321 0.200 (a) 0.100 (a) 0.100 (a) 0.200 (a) 0.133 (a) 0.133 (a) 
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the attributes related to texture, such as firm, soft, dry and moist. There were also 
differences observed in the appearance attribute fatty/oily and in the aftereffect attributes 
mouth-drying and oily.  
A contingency table with the sum of attribute tables across the assessors is used to 
construct a correspondence analysis (supplementary data). The independence between the 
rows (attributes) and the columns (products) is tested using chi-square test and it is found 






4.1 Introduction to discussion 
Inflammatory and thrombotic events are implicated in all stages of atherosclerosis and 
CVD (Tsoupras et al., 2018b). Activation and aggregation of platelets are crucial parts 
of vascular physiology and pathophysiology, and thus in cardiovascular diseases 
(Tsoupras et al., 2018b, Stokes and Granger, 2012). Such processes can be induced by 
several platelet agonists, with the inflammatory and thrombotic mediators PAF and 
thrombin being the most potent ones, but also to a lesser extent by collagen and ADP 
(Tsoupras et al., 2018b, Demopoulos et al., 2003, Li et al., 2010, Tsopanoglou and 
Maragoudakis, 2009, Stokes and Granger, 2012, Tsoupras et al., 2019c).  
Healthy dietary patterns have exhibited beneficial outcomes against atherosclerosis and 
CVD (Tierney et al., 2019).  Several bioactive compounds from foods and fish of such 
diets, including salmon, have exhibited strong antithrombotic effects against platelet 
aggregation induced by PAF and thrombin (Tsoupras et al., 2018b, Lordan et al., 2017, 
Tsoupras et al., 2019a, Tsoupras et al., 2018a, Nasopoulou et al., 2011, Kalogeropoulos 
et al., 2008, Antonopoulou et al., 2005). Salmon is characterised as an oily fish that 
several nutritional guidelines have proposed to be included in healthy diets (Lara et al., 
2007). Recently, bioactive lipids of salmon have been found to possess strong 
antithrombotic effects against not only PAF and thrombin but also against collagen and 
ADP pathways (Tsoupras et al., 2019a, Tsoupras et al., 2019c, Tsoupras et al., 2019d). 
Epidemiologic studies have shown that high dietary consumption of salmon and other 
oily fish, such as herring and trout, is associated with reduced rates of myocardial 
infarction, atherosclerosis, and other ischemic pathologies (Appendix 1). However, it is 
important to state that salmon is mainly consumed cooked. The majority of the studies 
related to the effects of cooking to salmon are related mainly to the effects on its fatty 
acid composition, while reduction of its health benefits are mostly corelated with any 
changes in n-3 PUFA content in cooked salmon (Tierney et al., 2019, Goel et al., 2018, 
Ferraro et al., 2013) . 
To the best of our knowledge, there aren’t any studies reporting the effects of cooking, 
and especially of mild cooking techniques such as sous vide on the bioactive salmon 
PLs. This is the first study examining the effects of mild sous vide cooking procedures 
66 
 
on the bio-functionality and fatty acid content of salmon PLs in different conditions 
applied. More specifically, in this study we applied different temperatures 52°C, 65°C 
and 80°C) and brining conditions in order to evaluate the optimum conditions of sous 
vide that has the minimum effects on the functionality and fatty acid content of salmon 
PLs. 
 
4.2. Effects of different sous vide preparations on the yield of 
extraction and separation of bioactive salmon PLs 
The TL, TNL and TPL were extracted from the Irish organic farmed salmon (Salmo 
salar) subsequent to the various different sous-vide cooking preparations and used for 
analysis. Previous research has demonstrated the antithrombotic bioactivities that the 
TPL of raw Irish organic farmed salmon possess against PAF, thrombin collagen and 
ADP (Tsoupras et al., 2019c, Tsoupras et al., 2018a, Tsoupras et al., 2019a) and 
unpublished data communicated from Dr. Alexandros Tsoupras. Several other lipid 
extraction methods exist, for example (Folch et al., 1957). However, for this study we 
used a well- established extraction technique combined with the appropriate counter-
current distribution technique to  extract the highest efficacy of TPL from the TL extract 
of natural source, namely the Bligh & Dyer method (Bligh and Dyer, 1959).  By 
applying such methodology in several fish species, including salmon, it is now well 
established that within the TPL fraction of such separations contains highly bioactive 
marine polar lipids. For this reason in the present study, we also applied similar 
methodologies with the one used in raw salmon (Tsoupras et al., 2018a) in order to gain 
maximum efficacy in obtaining the bioactive TPL from cooked salmon samples.  
Salmon, which is classified as an oily fish species, is reported to contain high levels of 
TL as opposed to other fish species (Zhang et al., 2012b).  Furthermore, the majority of 
extracted lipids belong to the more neutral classes of lipids, which combined are 
classified as TNL. As a result, of the TNL fraction contributing to approximately 60-
84% of the raw salmon TL. Subsequently raw salmon TL contain lower amounts of the 
more polar classes of lipids, which combined are classified as TPL; the TPL fraction 
consist approx.16-40% of the salmon TL (Tsoupras et al., 2018). 
Previous studies performed by Tsoupras et al., 2018 investigated the antithrombotic 
activities of polar lipids extracted from raw Irish organic farmed salmon (Salmo salar) 
and lower levels of TL, TNL and TPL were extracted upon comparison to all cooked 
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salmon samples in this study. Larsen et al., 2010 hypothesized that the lipids were 
extracted more effectively from cooked fish samples rather than raw fish due to the 
bound lipids being released as free lipids during the cooking process therefore, leading 
to an increased lipid extraction. The increase in lipid extraction from cooked salmon 
upon comparison to raw salmon could be as a result of mechanical factors during the 
homogenisation step of the Bligh & Dyer method (1959). The softer tissue of cooked 
fish is more efficiently homogenised enabling more lipids to be extracted. Various 
different lipid extractions have been used throughout the literature on fish therefore, it 
remains difficult to compare lipid extraction quantities on the same fish species (Al-
Saghir et al., 2004, Candela et al., 1998, Ågren and Hänninen, 1993).  
Therefore, it may be possible that in our samples, it seems that a higher release of NL 
during the cooking process lead to an increase in lipid extraction in TNL and 
subsequently in TL, whereas the TPL was similar. The % TL was lower in the cooked 
salmon samples when compared to raw, the fact that the absolute values of TPL 
(g/100g) did not change between the raw salmon and the sous-vide cooked salmon. It 
was reported  that an increase in TL from cooked fish samples was due to the loss and 
changes in other lipid materials in the fish muscles (Mai et al., 2006). It was also 
suggested that TL in cooked fish samples was due to the polymerisation and/or 
oxidation of the triglycerides (Bakar et al., 2008) 
 
4.3 The effect of several sous-vide cooking preparations on the bio-
functionality of salmon PLs against platelet aggregation 
The consumption of fish and fish oils has improved platelet function, human 
thrombosis, and haemostasis in several disorders (Knapp, 1997, Mori, 2018, Axelrod et 
al., 1994, Mori et al., 1997, Goel et al., 2018). These effects have primarily been 
attributed to the EPA and DHA content of fish through mechanisms related to the 
eicosanoid pathways (Goel et al., 2018).  However, several recent reviews and meta-
analyses have indicated that there is insufficient evidence for any benefits from n-3 
PUFA supplements, in the form of purified fatty acids or in the form of esters, on 
reducing the risk for CVD (either on primary or in secondary prevention) and on 
lowering the risk of all-cause mortality, cardiac death, sudden death, myocardial 
infarction, stroke, or cancer (Enns et al., 2014, Walz et al., 2016, Manson et al., 2019, 
Rizos et al., 2012, Kwak et al., 2012, Chowdhury et al., 2012, Lordan et al., 2017) 
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Remarkably, several of these studies have also proposed that the beneficial effect of fish 
intake on cerebrovascular risk is likely to be mediated through the interplay of a wide 
range of nutrients abundant in fish (Chowdhury et al., 2012, White and McHowat, 
2007, Lordan et al., 2017). Within this concept, promising outcomes have been 
attributed to polar lipids (PLs) of marine origin (Lordan et al., 2017) especially those 
bearing n-3 PUFA within their structure that were found also in salmon (Lordan et al., 
2017, Antonopoulou et al., 2005). 
PLs from raw salmon have been recently found to possess strong anti-inflammatory, 
antithrombotic, and cardio-protective activities against platelet activation and 
aggregation induced by inflammatory and thrombotic mediators such as PAF and 
thrombin, but also against well- established platelet agonists such as collagen and ADP 
(Tsoupras et al., 2019a, Tsoupras et al., 2019c, Tsoupras et al., 2019d) and  unpublished 
data communicated by Dr Alexandros Tsoupras. 
It is well established that platelet activation and aggregation is a well- defined risk 
factor for CVD (Tsoupras et al., 2018b). Moreover, European Food Safety Authority 
(EFSA) has declared as one of the health claims related to CVD for a food or a food 
product (functional food, food supplement, nutraceutical, etc) its ability to reduce 
platelet aggregation. Therefore, in this study we studied the effects of cooking on the 
capability of salmon bioactive compounds to inhibit platelet aggregation. More 
specifically, within this study, we examined the effects of mild cooking procedures, 
such as sous vide, in several conditions of temperatures and the effect of brining on the 
bio-functionality of salmon TPL against platelet aggregation induced by the platelet 
agonists, PAF, thrombin, collagen and ADP, in human platelet preparations (EFSA 
2011). 
The effects of cooking on fish PL bioactivities against platelet aggregation has been 
previously studied in cod (Panayiotou et al., 2000) and sardines (Nasopoulou et al., 
2013. Moreover, in these studies they have used washed platelet preparations, and 
examined solely, PAF. The novelty of this study is the effects of cooking on the bio-
functionality of TPL obtained from salmon, a native Irish oily fish, against platelet 
aggregation of human platelet rich plasma (hPRP), induced not only by PAF, but also 
by thrombin, collagen and ADP. 
In this study we performed milder cooking preparations according to the sous vide 
technique which differs from to the cooking techniques used in cod and sardine cooking 
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studies (frying and grilled), in order to evaluate if in these milder conditions  have better 
preservation of the bioactivities of salmon TPL. 
The bioactivities of TPL from cooked salmon against platelet aggregation were tested in 
human platelet preparations of hPRP according to (Tsoupras et al., 2019d) and not in 
washed platelets as it was investigated in the cases of cod and sardine. The use of hPRP 
provide the benefit to investigate the bioactive salmon TPL in more physiological 
media, and its binding is not altered by plasma proteins and other plasma constituents, 
which is closer to the in vivo conditions. 
Furthermore, in contrast to the previous studies in cod and sardine, in the present study 
we examined the effects of sous vide cooking on the bio-functionality of salmon TPL 
against platelet aggregation induced not only by PAF, but also by other well established 
thrombotic and platelet activation agonists such as thrombin, collagen and ADP, in 
human platelet preparations. This was done so, in order to obtain an overall evaluation 
of the effects of cooking on the anti-thrombotic activities of salmon TPL with respect to 
most well renowned pathways involved in platelet aggregation that are also recognised 
by EFSA. Such holistic approaches facilitate the overall evaluation of the effects of sous 
vide on the bio-functionality of salmon TPL against all platelet aggregation related 
pathways.  
It should be mentioned that in the present study, samples were of Irish organic farmed 
salmon origin were used in order to compare the anti-thrombotic effects of sous vide 
cooked salmon from the salmon of the same lot number, the same supplier and of the 
same quality to previous studies performed by (Tsoupras et al., 2018a, Tsoupras et al., 
2019a). 
Salmon fillets were cooked by the sous vide technique in several cooking temperatures 
(52°C, 65°C and 80°C), while for each different temperature a sample was either brined 
or un-brined by a 10% sodium chloride to water solution. From the literature, the 
optimum sous-vide cooking temperature for salmon, in order to maximise taste and 
texture qualities was 52°C (Brookmire et al., 2013). The 80°C temperature was used as 
this is a standard temperature for the pasteurisation of food (González-Fandos et al., 
2005). The median temperature of 65°C was used in order to evaluate the effects of the 
intermediate temperature of sous-vide cooking of salmon samples on its anti-thrombotic 
properties. Brining is a common technique used by chefs worldwide to improve the 
texture of cooked fish to prevent it from flaking upon cooking,  hence that is why we 
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used the brining process (Jittinandana et al., 2002).  It is thus important to study on an 
individual basis the effect of different temperatures and brining conditions on the 
composition of lipids and any possible change on the biological activity of these lipids.  
The in vitro antithrombotic properties of the TPL of all these samples against human 
platelet aggregation the action of PAF/Collagen/Thrombin/ADP-induced in human PRP 
(hPRP) with the results displayed in Figures 3.2-3.5. All the results are expressed as 
IC50 values, which are described as the mass of lipid measured in micrograms (µg) that 
is necessary to induce half the maximal-reversible aggregation caused by 
PAF/Collagen/Thrombin/ADP-induced platelet aggregation (Tsoupras et al., 2019d).  In 
general, the half maximal inhibitory concentration (IC50) is a measure of the potency of 
a substance in inhibiting a specific biological or biochemical function. IC50 is a 
quantitative measure that indicates how much of a particular inhibitory substance (e.g. 
drug/bioactive compound, etc.) is required to inhibit, in vitro, a given biological process 
or biological component by 50%, and thus it is the most effective and well-established 
value for comparing the potency of two or more bioactive inhibitors/compounds. These 
are some of the reasons for using in our study IC50 values for comparisons of the 
inhibitory strength of each lipid sample from all the sous vide salmon preparations 
against PAF, thrombin, ADP and Collagen induced platelet aggregation. 
In the present study, it was found for the first time that mild sous vide preparations from 
52°C until 65°C did not affect the bio-functionality of salmon TPLs with strong 
antithrombotic bioactivities against well-established platelet-agonists, namely PAF, 
thrombin, collagen, and ADP. The strong anti-platelet effects of the TPL from these 
sous vide preparations were also found to be comparable to the relevant effects of the 
raw SFs and to other fish species (Tsoupras et al., 2019a, Tsoupras et al., 2018a, 
Nasopoulou et al., 2007, Nasopoulou et al., 2013, Panayiotou et al., 2000)  
More specifically, PLs from brined and un-brined sous vide salmon preparations at 
52°C and 65°C were found to strongly inhibit the PAF pathway of human platelet 
aggregation, an effect that was found to be similar with the PLs from the raw SFs 
(Tsoupras et al., 2018a, Tsoupras et al., 2019a) but also with other edible fish species 
(Lordan et al., 2017, Nasopoulou et al., 2013, Panayiotou et al., 2000).  
However, by applying higher temperatures, such as those used for pasteurisation (80°C) 
the anti-PAF effects of cooked salmon were decreased, in both brined and un-brined 
sous vide salmon preparations, compared to all the other sous vide salmon preparations 
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and when compared to raw SF. When the temperature increases in the sous-vide 
cooking process, a considerable reduction in the potency of anti-PAF effects was 
observed. These results are in accordance with the previous reported results in cooking 
preparations (grilling) in another oily fish, namely sardines, in which a decrease in the 
anti-PAF activities of sardine TPL was also observed in high temperature of grilling in 
comparison to raw sardines (Nasopoulou et al., 2013).  
PAF is a potent inflammatory mediator implicated in the development and progression 
of atherosclerosis, CVDs and other inflammation-related chronic disorders.(Tsoupras et 
al., 2018a).  The preservation of the bio-functionality of TPL when applying sous vide 
producing cooked salmon as a functional food, even if cooked, with strong anti-PAF 
activities and thus potent anti-thrombotic and cardio-protective properties 
In raw SF the anti-PAF effects of salmon TPL were stronger than their antithrombin 
(Tsoupras et al., 2018a).  These results have proposed that the bioactive TPL from SF 
possess higher specificity against the PAF-pathway, rather than the thrombin pathway 
(Tsoupras et al., 2018a).  After sous vide cooking to 52°C-65°C the antithrombin effects 
of TPL from cooked SF were similar to the anti-thrombin effects of raw SF TPL. 
Therefore, the anti-thrombin effects of TPL from sous vide preparations in both 52°C 
and 65°C were again less potent than their anti-PAF activities, suggesting that the 
higher specificity of salmon TPL against PAF in comparison to their anti-thrombin 
effects was preserved. 
However, by applying higher temperatures, such as those used for pasteurisation (80°C) 
the anti-thrombin effects of cooked salmon were again decreased, in both brined and un-
brined sous vide salmon preparations, compared to all the other sous vide salmon 
preparations and when compared to raw SF. 
This is the first study examining the effect of general cooking in bio-functionality of 
bioactive PLs from a food source in relation to their anti-thrombin effects but also 
against collagen and ADP induced platelet aggregation. Platelets are endowed with a 
repertoire of surface receptors that enable them to adhere, activate and aggregate upon 
vascular injury by several mediators and their related pathways, such as PAF (Tsoupras 
et al., 2018c). Apart from PAF, platelet adhesion is governed by the interaction between 
vascular collagen and its related receptors on platelet membranes and the engagement of 
other soluble agonists, predominantly ADP, Thromboxane A2 (TXA2) and thrombin, 
with their related Gq-protein coupled receptors (Vilahur et al., 2018). Therefore, an 
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understanding of  the platelet signalling mechanism involved in thrombus formation by 
all these agonists and their related pathways is necessary to identify the overall 
antithrombotic properties of food related antiplatelet agents, such as the bioactive 
salmon TPL. 
Concerning the anti-ADP effects of salmon TPL, by applying mild temperatures in the 
sous vide preparations (52°C and 65°C) either brined or un-brined, the strong inhibitory 
effects of salmon TPL against ADP-induced platelet aggregation were preserved in 
similar potency with those of the raw SF (Unpublished data communicated by Dr 
Alexandros Tsoupras). Similar to the changes observed on the anti-PAF activities of the 
salmon TPL after sous vide cooking, it was also observed that the anti-ADP effects of 
salmon TPL were significantly reduced when higher temperatures were applied (80°C 
brined and un-brined) during sous vide preparations. PAF-pathway of platelet 
aggregation is related to the intracellular changes within platelets after the binding of 
PAF on its specific for PAF G-coupled protein receptor, namely PAF-receptor. 
Intracellular signalling triggered by such an initial PAF-related signal is that of the 
eicosanoids and of ADP, which concludes in release and secretion of ADP from platelet 
granules to enhance the initial signal (related to PAF) by a further activation of platelets 
by the ADP-pathway too, resulting in platelet aggregation and thrombus formation 
(Tsoupras et al., 2019b). Thus, PAF, eicosanoids and ADP pathways are inter-related, 
and the anti-PAF effects of food food-derived bioactive TPL including salmon TPL 
seem to be related with their anti-ADP effects. The aforementioned explain the 
observed similarities between the changes found in the anti-PAF and anti-ADP 
activities of salmon TPL after cooking.  
Another interesting pathway for inducing platelet aggregation that recently has received 
plenty of attention as a target for drug and food supplement development, is that related 
to collagen (Vilahur et al., 2018). One of the events that triggers platelet tethering to the 
site of vascular injury occurs upon subendothelial collagen exposure, mostly fibrillar 
types I and III, to the circulation. Collagen mediates platelet adhesion by interacting 
with a range of unique surface platelet receptors. Binding of Collagen on these receptors 
activates by specific intracellular signalling the aggregation of platelets by specific 
pathways. The ability of salmon TPL to inhibit the collagen pathway is of great 
importance for the endothelium platelets interaction during atherosclerosis and 
atherothrombosis. Notably, bioactive TPL from raw salmon have recently exhibited 
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strong anti-collagen effects (Unpublished data communicated by Dr Alexandros 
Tsoupras). 
Within the present study, it was also found that mild cooking sous vide preparations in 
52°C preserved these strong anti-collagen effects of salmon TPL Interestingly, and 
differently than what happened to all the effects of salmon TPL against all the other 
platelet agonists, the TPL from 65 brined and un-brined sous vide salmon preparations 
exhibited highly potent anti-collagen effect which was significantly stronger than the 
anti-collagen effects of TPL from either the 52°C or the raw SF.  
Similarly, the anti-collagen effects of the TPL from salmon sous vide preparations were 
preserved even when higher temperatures were applied (80°C) either in brined or in un-
brined salmon preparations. 
Differently than SF, salmon PLs from sous vide preparations of SH at 80°C exhibited 
similar antithrombotic properties against platelet aggregation induced by PAF, ADP and 
collagen with those of salmon PLs from raw SH (Tsoupras et al., 2019c). A reduction 
was observed only in the anti-thrombin properties of SH-PLs from both brined and un-
brined sous vide preparations at 80°C, in comparison with those of the raw SH in 
human platelets (Tsoupras et al 2019). SH were chosen to be also tested in this study, 
since they are the main by-product of fish industries of salmon products, and thus its 
valorisation is crucial for sustainable development (Tsoupras et al., 2019c). In addition, 
SH are consumed in several places globally (Ferraro et al., 2010). Higher temperatures 
(80°C) were applied in order to overcome the different and more dense structure of 
these salmon samples. Notably, the higher preservation of the antithrombotic properties 
of salmon PLs from cooked SH in comparison to that of the cooked SF seems to be 
related with this structural and textural difference of SH to SF samples, since the overall 
tissue structure of the SH seem to encase the bioactive PLs within. However, more 
studies are required to fully evaluate the differences observed in the antithrombotic 
properties of salmon PLs from sous vide SH and SF preparations. 
The variance on the changes observed in the anti-platelet effects of the bioactive salmon 
TPL against not only PAF, but also against all the other platelet agonists studied 
(thrombin, collagen and ADP), during sous vide processing in different temperatures 
and brining conditions, seem to be related to alterations of the fatty acid composition in 
these salmon TPL. For example, changes in the content of DPA of the bioactive salmon 
TPL in different temperatures may be related to the differences in their anti-collagen 
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activities, since DPA is related to inhibition of the collagen pathway (Murugappa and 
Kunapuli, 2006). DPA content was increased in the TPL from sous vide salmon 
preparations in 65°C, compared to those in other temperatures, which may explain the 
stronger anti-collagen effects of the TPL derived from sous vide salmon in this 
temperature, rather than those in raw salmon fillets or in lower (52°C) and higher 
(80°C) temperatures. In addition, changes observed in both EPA and DHA content 
when observed when higher temperatures were applied may also be related to the 
reduction of the anti-PAF, anti-thrombin and anti-ADP effects of salmon TPL. 
An overall evaluation of the effects of sous vide cooking on the changes of the fatty acid 
composition of bioactive salmon TPL in relation to their observed anti-platelet effects 
against all platelet agonists tested (PAF, thrombin, collagen and ADP) is further 
discussed in the following section. 
 
4.4 The effect of several sous-vide cooking preparations on the fatty 
acid content in relation to the bio-functionality of salmon PLs 
Previous elucidation of the structure activity relationship suggested that specific 
phospholipid moieties bearing ω3 PUFA, such as EPA and DHA, in their sn-2 position 
of their glycerol backbone, either belonging to alkyl-acyl-PLs or acyl-acyl-PLs, seem to 
be present in most bioactive subclasses of the SFs, providing a rational for their strong 
antithrombotic effects (Tsoupras et al., 2018a, Tsoupras et al., 2019a). Furthermore, it 
has been previously reported that cooked salmon also contains phospholipids bearing 
considerable amounts of n-3 PUFA 
Within our study, by applying LC-MS analysis according to Tsoupras et al (Tsoupras et 
al 2019a), we also found that sous vide preparations of salmon in several different 
temperatures and/or brined/un-brined  contain high amounts of PLs bearing PUFA 
within their structure, the majority of which were n-3 PUFA and especially DHA and 
EPA, similar to the raw salmon (Tsoupras et al., 2018a). These results were shown in 
Figure 3.6 and the absolute values appear in the APPENDIX III. Considerable amounts 
of n-6 fatty acids were also present with the most abundant being linoleic acid followed 
by less amounts of arachidonic acid. On the other hand, all samples exhibited high 
levels of saturated fatty acids, specifically, palmitic acid being the most abundant, 
followed by stearic acid in all samples. Furthermore, the most prominent MUFA was 
found to be oleic acid followed by gadoleic acid. All these results are in accordance 
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with previous reports in raw (Tsoupras et al., 2018a) and cooked salmon (See Table 1.1 
and Table 1.4). 
More specifically, in both brined and un-brined salmon sous vide preparations in 52°C 
(brined and un-brined) the fatty acid composition of salmon we reported that SFA and 
MUFA increased, whereas PUFA were decreased because n-6 were decreased but n-3 
remained similar to raw SF. Therefore, it is possible that the double bonds of n-6 PUFA 
broken from cooking into the relative SFA and MUFA. It seems that n-6 are more 
susceptible to cooking procedures rather than the n-3. Instead, the n-3 PUFA remained 
unaffected by these mild procedures.  Overall, n6/n3 was found to be approximately at 
the range of the value 1/1, which is much lower than that of Westernised diets that is 
within the range of 5/1–20/1 (Simopoulos, 2002).  It has been reported that high values 
of this ratio are correlated with a higher risk in cardiovascular disease and other chronic 
diseases (Simopoulos, 2002). Taking this into account, the observed favourable n-6/n-3 
ratio in the bioactive TPL from 52°C further supports the preservation of the 
cardioprotective properties for PLs from 52°C sous vide salmon since low values for this 
ratio seem to provide several beneficial health outcomes in CVD and other chronic 
disorders (Simopoulos, 2016).  Interestingly, this ratio was also preserved in values within 
the range of 1/1 even when higher temperatures were applied. In these conditions of sous 
vide processing in 65°C and 80°C, there was a decrease observed in both n-6 and n-3 
which may explain why the n-6/n-3 ratio remained relatively unaffected.   
Interestingly, when higher sous-vide cooking temperatures were applied, a reduction was 
observed in the EPA content of salmon TPL in both 65°C and 80°C in un-brined sous 
vide preparations, while a similar reduction was also observed in their DHA content only 
in the 80°C un-brined samples. These changes are related to the reduction of the anti-
platelet effects of salmon TPL against all platelet agonists tested (PAF, thrombin, 
collagen and ADP) when temperatures of  80°C was applied, since the most bioactive 
TPL in salmon have been previously proposed to be the ones bearing such n-3 PUFA 
within their structures (Tsoupras et al., 2018a, Tsoupras et al., 2019a).It is proposed  that 
the breakdown of these n-3 PUFA on the salmon TPL as a result of the higher temperature 
was  applied, are related to the reduction of the bioactivities of the most bioactive salmon 
TPL against platelet aggregation. These results are in agreement with previous results on 
sardine cookery (Nasopoulou et al., 2013). 
Even though there was such a reduction observed in both the EPA and DHA content and 
therefore in the anti-platelet activities of salmon TPL in high cooking temperatures 
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against PAF, thrombin and ADP, still the bioactivities of salmon TPL against these 
platelet agonists in these high temperatures were not diminished and were preserved at 
considerable levels, while their anti-collagen effects remained relatively unaffected. 
These outcomes further suggest that salmon is still a functional food against platelet 
aggregation with low n-6/n-3 ratio with cardioprotective properties, even when cooked in 
such high temperatures, lower than 100°C (80°C). Further studies are needed in order to 
evaluate the effects of applying higher temperatures with appropriate cooking techniques 
on the overall anti-platelet effects of salmon TPL.  
In contrast to the un-brined samples, in brined samples when the same higher 
temperatures were applied, there was not a significant decrease of both EPA and DHA 
content in the bioactive salmon TPL. This finding in all brined salmon samples before 
and after sous vide preparations differ from previously reported reduction of EPA and 
DHA when brining another oily fish such as sardines (Nasopoulou et al., 2013). Our 
results suggest that brining in salmon may not affect the n-3 content of salmon even 
when cooked between the temperatures of 52°C to 80°C by mild sous vide cooking 
processing.  
Furthermore, a decline in the anti-platelet effects of salmon TPL was observed against 
PAF, thrombin and ADP. Therefore, such a reduction on the anti-platelet effects of 
brined samples against these platelet agonists seem to be related to the effects of higher 
temperatures in other type of bioactive PLs. It should also be stressed that the bioactive 
marine TPL extracts contain several bioactive PL subclasses either of phospholipid or 
glycolipid moieties or of both, with several fatty acid content. The bioactivities of these 
PL are usually related with the degree of unsaturation of their FA content and the 
positions of their double bonds. But this is not the case for all bioactive PLs. For 
example, there are bioactive alkyl-acyl PLs with strong anti-PAF activities, without 
being highly unsaturated (Tsoupras et al., 2018b). In addition, in sea bass, specific 
peculiar glycolipids exhibited the most profound anti-platelet effects against PAF 
(Nasopoulou et al., 2014, Tsoupras et al., 2011,2012). Therefore, further studies are 
required with implementing overall structural analysis of the PL involved, for further 
evaluation of the changes in the total structures of the bioactive salmon TPL by such 
sous vide preparations and their structure activity relationships.  
Nevertheless, by applying mild cooking sous vide processing the preservation of the 
potent antithrombotic properties of the bioactive salmon TPL against inflammatory and 
thrombotic mediators such as PAF and thrombin, but also against well-established 
77 
 
platelet agonists such as collagen and ADP, along with the preservation of their n-3 
content and n-6/n-3 ratios, highlight both the bio-functionality of cooked salmon and the 
efficacy of the sous vide technique. 
This is of great significance, since salmon is consumed mostly cooked. Therefore, if in 
cooked salmon such bioactive compounds are preserved, during consumption of cooked 
salmon a considerable proportion of such bioactive food-derived PL remain intact 
during digestion (Lordan et al., 2017, Burri et al., 2012) After their absorption into the 
blood stream through the intestinal tract, the polar head of bioactive PL amphiphilic 
moieties facilitate their superior incorporation into blood lipoproteins and their more 
effective transfer to several tissues and blood cells membranes, including platelets, 
when compared with other neutral forms of ω3 PUFA, such as FFA, esters or TAG 
(Burri et al., 2012, Lordan et al., 2017, Tsoupras et al., 2019a).  Thus, the amphiphilic 
properties of such bioactive PL facilitates their superior bioavailability of their ω3 
PUFA content, which indicates that they are more effective and influential on platelet 
functionality in comparison with the aforementioned neutral forms of n-3 PUFA 
(Tsoupras et al., 2018a, Tsoupras et al., 2019a). 
When in the membranes of blood cells, including platelet membranes, such bioactive 
salmon PLs, can beneficially inhibit platelet-activation, either by their direct binding 
and effects on platelet membrane receptors related to platelet-aggregation, or by their 
indirect effects on the lipid-related microenvironment of such receptors, and/or by an 
overall indirect effect on platelet aggregation by affecting the functionality and 
polarisation of platelet membranes (Tsoupras et al., 2018b, Mori, 2017, Li et al., 2010, 
Tierney et al., 2019, Lordan et al., 2017, Tsoupras et al., 2018a, Tsoupras et al., 2019a) 
Since recent findings have exhibited that platelet-activation induced by pathways 
associated with PAF, thrombin, collagen, and ADP, seems to be inter-connected and 
interrelated in several inflammation and thrombosis related manifestations (Tierney et 
al., 2019, Tsoupras et al., 2018a, Tsoupras et al., 2019a, Stokes and Granger, 2012, 
Mastenbroek et al., 2015, Vilahur et al., 2018, Keating and Schneider, 2009, Melnikova 
et al., 2008, Zimmerman et al., 1985), the overall beneficial antiplatelet effects of SPL 
against these platelet agonists strongly suggest that they possess cardioprotective 
properties, and well preserved when salmon is cooked in mild cooking conditions such 




4.4 Sensory Analysis 
The sous-vide cooking process allows for food stuffs of high nutritional quality and 
high sensory attributes to be preserved with a longer shelf life than other cooking-
cooling processes. Therefore, in this study, we performed sensory analysis on all sous 
vide salmon preparations in order to detect the changes in smell, taste, colour, juiciness 
as well as the appearance of off-flavours and off-odours during the sous vide cooking 
process (Diaz et al., 2009). 
In Table 3.8, it can be observed that the two sous-vide samples at 52o C were perceived 
more similar and were characterised by attributes such as Fatty/Oily Appearance, Strong 
Fishy Odour, Moist Texture. Whereas, the control samples (80°C) and the samples sous-
vide at 65o C were closer in the PCA plot and they were characterised as Flaky, Firm. 
This was expected since these samples were cooked at temperatures above 60oC. 
Cooking fish and meat results in improved taste, softer texture, increased safety, and 
improved nutrient digestibility (KADAM and PRABHASANKAR, 2012). The muscle of 
the fish separates into flakes at temperatures around 46-49°C (Ofstad et al., 1995). While 
collagen which is present in connective tissues, shrinks and solubilises at around 60oC 
and above 65°C is transformed into gelatine. Ofstad et al.,1993 tested salmon and cod 
fillets cooked between the temperatures of 50-70oC and reported that the maximum water 
loss from salmon flesh was at 50oC. After this point at temperatures above 60oC, various 
structural changes in the conjunctive tissue of the fish take place which can explain the 
changes in structure. These changes were detected by the judges.  Moreover, a more 
recent study by Kato et al., (2016) showed that the texture of fish cooked under sous-vide 
at temperatures higher than 65oC was significantly different from the raw fish. The 
changes in texture were measured using a texture analyser and no sensory data were 
collected for these samples (Kato et al., 2016) 
Interestingly there were not significant differences due to taste as it would be expected 
between the brined and un-brined samples. This was the case for both the CATA data and 
the napping data as seen in Figure 3.7 and Figure 3.8.  
Previous research (Alexi et al., 2018) has shown that CATA results obtained from semi-
trained panellists on CATA terms can be comparable to results from descriptive profiling. 
However, in this case although the panellists had conducted other sensory tests were not 
trained in the attributes used for CATA therefore they cannot be compared with the semi-
trained panellists from the study by Alexi et al (2018). On the other hand, the findings 
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from CATA are comparable to the findings from napping as seen in Figure 3.8. Indeed, 
as seen in Figure 3.7 samples cooked at 52°C were perceived different from the rest of 
the samples. The fact that CATA and napping findings were in agreement to corroborated 
by the findings of Reinbach et al., (2014) who got comparable information from CATA 








 Sous vide salmon preparations in mild conditions (52°C-65°C) of both brined and 
un-brined salmon resulted in preservation of the antithrombotic properties of 
bioactive salmon PLs against human platelet aggregation induced by the 
inflammatory and thrombotic mediators’ platelet-activating factor (PAF) and 
thrombin, but also by the well-established platelet agonists adenosine diphosphate 
(ADP) and collagen. 
 However, higher temperatures such as those applied for pasteurization (80°C) 
resulted in reduction of these antithrombotic properties, which was accompanied 
by a reduction in the EPA and DHA content of salmon PLs, especially in the un-
brined sous vide salmon preparations at 80°C.  
 Nevertheless, fatty acid compositional analysis of all sous vide salmon 
preparations, showed that even though there were variances observed on the FA 
content in different temperatures, especially for the un-brined salmon samples, the 
overall n-6/n-3 ratio of their PUFA content was also preserved in low values 
within the beneficial range of the 1/1 value for CVD. 
 Sous vide salmon preparations in all conditions did not affect the taste, whereas 
in 65°C and 80°C slight textural differences were observed. 
 Emerging cooking techniques, such as sous vide seem to be the optimal 
procedures for preserving the bioactivities and fatty acid composition of salmon, 
without affecting its taste and texture 
 Further studies are needed in order to fully evaluate the benefits and drawbacks 




















Comparison of krill oil (KO) supplementation and fish 
consumption with similar amounts of n-3 FA on the  
cardiovascular risk markers 
Fasting serum TAG did not change. TL (P=0.007), PL 
(P=0.015), cholesterol (P=0.009), cholesteryl ester 
(P=0.022), all increased in KO supplementation. Blood 
glucose decreased (P=0.0024) in KO group. Vitamin D 
increased in fish group (P=0.024). Plasma levels of marine 













Compare the effects of twice per week consumed farmed 
Atlantic salmon at doses 90,180 and 270g and its effects 
on plasma phospholipids FA proportions and various 
CVD risk biomarkers 
No changes were observed in any CVD risk biomarkers in 
either group. Salmon intake changed Plasma Phospholipid n-
3 and n-6 FA proportions. Arachidonic acid decreased 
(P=0.0002) with salmon dose independent. No change in LA 
in all treatments. Total n-3 reduced (P<0.0001). EPA 
increased in a dose-dependent manner (P<0.0001). DHA 
increased in all treatments (P<0.0001). Total n-3 increased 
dose dependent manner (P<0.0001) and EPA+DHA 
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increased (P<0.0001). n-3:n-6 ratio decreased (P<0.0001) in 







To assess the impact of the source of n-3 FA on their 
incorporation in serum, on blood lipid composition and 
on cellular activation. 5 groups involved in trial. 3 
groups given 400g fish per week for 8 weeks (smoked 
salmon, salmon & cod). 4th group given 15ml/day cod 
liver oil and 5th group as control with no 
supplementation 
EPA and DHA in cooked salmon increased (129% in EPA 
and 45% in DHA) compared to CLO (106% EPA and 25% 










a 4 -week 
washout 
period 
To test the hypothesis that oil-rich fish consumption 
improved CHD risk factors. Non-obese healthy subjects 
consumed 125g/day of salmon over 4- week period 
followed by 4-week washout period. Subjects were 
instructed to maintain dietary and physical activity 
patterns during trial 
Compared to no-fish, salmon consumption significantly 
reduced systolic, diastolic and mean arterial BP by 4%, TG 
by 15% and LDL-C by 7%. HDL-C increased significantly 
by 5% (P<0.05). Plasma adiponectin showed a trend toward 
improvement (8.39µmmol/L with salmon and 7.52µmmol/L 
with no-fish; P=0.086). No significant changes were found 










The effect of a 4-week herring diet compared to a 
reference diet on biomarkers for CVD in obese patients. 
Subjects were randomly assigned to 4- week diet of 
150g baked herring/day for 5 days/week or reference 
diet (pork and chicken fillets) and switched diets after 2- 
week washout. 
P-HDL was significantly higher in herring diet (1.22 vs 
1.13mmol/L P=0.036). Small but no significant decreased in 
TAG, no effect on other biomarkers. TEAC and FRAP, but 
not ORAC-values indicated that plasma antioxidants may 







Assessed the effect of dietary intervention with oily fish 
on platelet-monocyte aggregation in healthy subjects. 14 
subjects had their diet supplemented with 500g of oily 
fish per week for 4 weeks. The control group of 14 
subjects had no dietary supplementation 
Oily fish group had an increase in n-3 FAs in plasma 
phospholipids (14.2 ± 3.4% vs 5.8 ± 1.3%, P>0.001. In 
contrast to control group, platelet-monocyte aggregation was 
reduced by 35% with oily fish consumption (16.0 ± 9% to 
24.8 ± 10.9%, P<0.01) and returned to basal levels 4 weeks 
after discontinuation of supplement. Inverse correlations 
were observed between platelet-monocyte aggregation and 
plasma n-3 FA concentrations (R=0.421, P=0.006).No 





The effect of high intake of lean or fatty fish on glucose 
tolerance, leucocyte membrane FA composition and 
leucocyte function in overweight adults. 68 healthy 
High intake of fatty fish, not lean fish, significantly 
improved glucose regulation 120mins postprandially 
(P=0.012) but did not affect fasting glucose concentrations. 
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overweight/obese participants consumed 750g/week of 
either lean or fatty fish and control group avoided fish 
for an 8 -week period. Energy, macronutrient and 
physical activity was not altered during the study 
A small increase in fasting to 120mins postprandial insulin 
C-peptide concentration was observed after fatty fish intake 
(P=0.012). Lean fish consumption increased DHA in 
leucocyte membranes (P=0.010) and fatty fish increased n-3 
PUFA content (P=0.00016) and reduced n-6 PUFA content 






trial with a 
crossover 
design 
The aim of this study was to elucidate the potentials of 2 
main dietary protein sources (lean seafood and non-
seafood) to modulate fasting and postprandial lipids in 
healthy subjects. After 3 week run in periods and 
separated by a 5 week washout period, 20 healthy 
subjects consumed 2 balanced diets that varied in main 
protein sources (60% of total dietary proteins from lean 
seafood or non-seafood sources for 4 weeks 
Compared to the non-seafood intervention, the lean-seafood 
intervention group reduced fasting (relative differences by 
diets: 0.31mmol/L: P=0.03) and postprandial (P=0.01) serum 
triacylglycerol concentrations. The lower serum 
triacylglycerol in chylomicrons and VLDLs (P=0.004), 
reduced fasting VLDL particle size (P=0.04) and a reduced 
postprandial concentration of medium sized VLDL particles 
(P=0.02). the lean seafood intervention prevented the 
elevated ratio of total cholesterol to HDL cholesterol in the 
fasted serum (P=0.03) and postprandial serum (P=0.01) 









The effect of fatty and lean fish intake on the lipoprotein 
subclasses was investigated. 33 patients with CHD aged 
61.0 ± 5.8 yrs were assessed. Subjects were randomly 
assigned to a fatty fish diet (n=11), a lean fish diet 
(n=12) or a control diet (n=10) for 8 weeks. Fish diets 
included at least 4 fish meals/week. Control group 
consumed lean beef, pork and chicken. NMR was used 
to determine lipoprotein subclasses and their lipid 
components. 
Concentrations of n-3 FAs and DHA increased in fatty fish 
group. Concentrations of cholesterol, cholesterol esters and 
total lipids in very large HDLs increased in fatty fish group 
(P=0.005, P=0.002 and P=0.007 respectively). Mean size of 
HDL particles in fatty fish group increased (9.8 ± 0.3 
Nm at baseline and 9.9 ± 0.4nm at baseline and 9.9 ± 0.4nm 
at the end of study; overall difference P=0.004). The fish 









126 Chinese women with hypertriacylglycerolaemia, 
aged 35-70 years, were assigned to 4 groups to consume 
80g fillets of oily fish (salmon, herring or pompano) or a 
mix of commonly eaten meats (pork/chicken/beef/lean 
fish) for 5 days/week over an 8 week period. 
The oily fish subgroup exhibited significant increases in 
intake of n-3 LC PUFA while decreasing dietary n-6:n-3 
PUFA ratio. Compared to the control group, significant 
increases of DHA, EPA + DHA and total n-3 PUFA in 
plasma choline phosphoglyceride was observed in oily fish 
group. Plasma TAG only reduced in herring and salmon 
groups. Upon baseline comparisons, the 3 oily fish diets 
significantly decreased serum concentrations of TAG, 
apoCII and apoCIII, but only salmon and herring diets 
significantly lowered TNF-α and raised adiponectin levels in 
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The comparison of the rate and extent of enrichment of 
blood cell membranes and plasma phospholipids with n-
3 FAs from either fish or fish oil capsules. Healthy 
premenopausal female volunteers were randomly 
assigned a daily average of 485mg EPA and DHA either 
from 2 servings of oily fish (salmon or albacore tuna) 
per week of from 1-2 capsules/week. 
After wk 16, EPA and DHA in RBCs increased from 4.0 ± 
0.6% of total FAs to 6.2 ± 1.4%  whereas,  it rose from 4.3 ± 
1% to 6.2 ± 1.4% in the capsule group (P<0.0001) for both. 
Similar results were observed in plasma phospholipids. EPA 
and DHA stabilized in the latter after 4 weeks but continued 
to rise to week 16 in RBCs. EPA in RBCs significantly 
increased (P=001) more rapidly in the fish group than in the 
capsule group during initial 4 weeks, but rates did not 
significantly differ between groups after that. Total FA 








The effects on CVD risk markers of reducing dietary n-
6:n-3 PUFA by changes in linoleic acid:α-linolenic acid 
and/or increasing LC n-3 PUFA. This study also tested 
whether decreases in LA:LNA modulate effects of LC n-
3 PUFA. 142 subjects over a 24wk period were 
Modest dietary manipulations of n-6 and n-3 PUFAs results 
in significant group X time interactions for serum 
triacylglycerols (TAGs; P=0.05) At 24 weeks, the control 
and 2 oily fish groups showed lower TAG than the white 
fish/sunflower group (P=0.05). Reductions in TAG, 
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randomly assigned to a control group or 1 of 4 
interventions. Intervention groups received 2 portions of 
oily fish (0.7g EPA+DHA) per week, and replaced 
habitual household fats with ones high in sunflower 
(high LA:LNA) or rapeseed (low LA:LNA) oil 
associated with increased oily fish intakes, were maximized 
when combined with lower dietary LA:LNA. There was no 







To investigate the association between fish consumption 
and levels of inflammatory markers among adults with 
no prior evidence of CVD. 1,514 men and 1,523 women 
enrolled. CRP, IL-6, TNF-α, serum amyloid A and 
WBC analysed. Dietary habits evaluated. 
88% of men, 91% of women reported fish consumption at 
least once a month. Compared to non-fish consumers, those 
that consumed >300g of fish/week reported an average 33% 
lower CRP, 33% lower IL-6, 21% lower TNF-α, 28% lower 
SAA and 4% lower WBCs (all P<0.05). Significant results 






investigated the effect of dose-dependent intake of 
farmed Atlantic salmon on lipoprotein particle (P) size 
and concentration. They hypothesized that low density 
lipoprotein (LDL)-P and high density lipoprotein 
(HDL)-P size and concentration would increase with 
salmon intake in a dose-dependent manner. Overweight, 
Intake of salmon reduced plasma and serum triglyceride 
(TG) concentrations and increased plasma HDL-C 
concentrations. The concentrations of large very low-density 
lipoproteins (VLDL)-P and chylomicron (CM)-P were 
reduced. Large LDL-P concentrations were increased in a 









adult participants (n=19) were enrolled to a cross-over 
designed clinical trial evaluating intake of farmed 
Atlantic salmon. In random order, participants were 
assigned to 90, 180 or 270g of salmon twice weekly for 
4-week dietary treatments. Following a 4-8 week 
washout period participants crossed over to another dose 
of fish intake until all treatments were completed. 
Plasma lipid concentrations were determined and serum 
lipoprotein concentrations and particle size were 
determined by nuclear magnetic resonance. 
reduced and that of LDL was increased. Total TG was 
reduced as was the TG content of VLDL-P and CM-P. twice 
weekly intake of farmed Atlantic salmon portions influences 
the lipoprotein particle size and concentration in a manner 




The IC50 numerical values 
 
Table 5.1. The in vitro antithrombotic properties of the TPL of all sous vide salmon preparations samples against platelet aggregation induced by PAF, 
thrombin, collagen and ADP, expressed in numerical mean IC50 values in micrograms (µg) of salmon TPL ± SD (N=3-7). 
 IC-50 values of salmon TPL 
against PAF 
IC-50 values of salmon TPL 
against Thrombin 
IC-50 values of salmon TPL 
against collagen 
IC-50 values of salmon TPL 
against ADP 
RSF 45.0 ± 22.0 382.0 ± 39.0 122.0 ± 24.0 135.0 ± 33.0 
52°CSVSNB 66.9 ± 46.5 292.0 ± 55.7 91.8 ± 25.1 152.1 ± 21.9 
    52°CSVSB 115.2 ± 62.5 300.0 ± 122.0 74.5 ± 14.4 132.6 ± 16.7 
    65°CSVSNB 119.4 ± 23.1 325.6 ± 121.2 59.1 ± 5.1 149.6 ± 15.2 
    65°CSVSB  78.6 ± 5.3 519 ± 326.4 53.1 ± 2.5 143.5 ± 17.9 
    80°CSVSNB 
    80°CSVSB 
268.7 ± 49.7 
222.7±110.2 
728.6 ± 181.8 
706.3±191.8
 
145.6 ± 64.8 
113.3±53.0
 
255.2 ± 109.2 
232.2 ± 49.6
 
Abbreviations: RSF = raw salmon fillets; 52CSVSNB = 52°C sous-vide cooked salmon no brine; 52CSVSB = 52°C sous-vide cooked salmon brined; 
65CSVSNB = 65°C sous-vide cooked salmon no brine; 65CSVSB = 65°C sous-vide cooked salmon brined; 80CSVSNB = 80°C sous-vide cooked 
salmon no brine; 80CSVSB = 80°C sous-vide cooked salmon brined  




Table 5.2 Fatty acid composition of the saponified Total Polar Lipids (TPL) from various cooking preparations of salmon fillets. Results are 
presented as percentage of the total fatty acid content (mean values, n=3) 
Fatty acids C 52 TPL B 52 TPL NB 65 TPL B 65 TPL NB PSVS TPL B PSVS TPL NB 
 
Caprylic 8:0 0.01 0.01 0.01 0.01 0.02 0.00 
Pelargonic 9:0 0.04 0.06 0.04 0.04 0.08 0.02 
Capric 10:0 0.02 0.03 0.01 0.01 0.02 0.02 
Undecylic 11:0 0.00 0.01 0.00 0.00 0.00 0.00 
Lauric 12:0 0.02 0.04 0.01 0.00 0.01 0.03 
Myristic 14:0 1.11 1.73 1.07 1.30 1.25 1.24 
Pentadecylic 15:0 0.00 0.06 0.02 0.01 0.04 0.02 
Palmitic 16:0 21.94 20.43 24.19 22.15 21.34 19.32 
Palmitoleic 16:1 ω7 c9 0.47 1.22 0.69 0.81 0.75 0.83 
Margaric 17:0 0.42 0.34 0.42 0.69 0.62 0.29 
Stearic 18:0 13.10 12.95 13.83 12.15 14.10 12.35 
Oleic 18:1  ω9 c9 21.14 20.56 17.82 19.75 18.34 33.90 
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Linoleic 18:2 ω6 c9,c12 8.08 9.04 8.49 8.47 9.26 6.83 
Linolenic (α) 18:3 ω3 c9,c12,c15 2.36 2.22 1.46 1.71 1.79 2.28 
Stearidonic 18:4 ω3 c6,c9,c12,c15 0.89 1.92 1.75 1.98 1.53 1.00 
Nonadecylic 19:0 0.03 0.03 0.17 0.08 0.06 0.03 
Arachidic 20:0 0.13 0.15 0 
   
Gadoleic 20:1 ω11 c9 7.60 8.95 9.03 10.71 9.49 8.02 
DihomoLinoleic 20:2 ω6 c11,c14 3.71 3.68 1.34 2.14 2.05 2.81 
Dihomolinolenic 20:3 ω6 c8,c11,c14 0.21 0.24 0.19 0.39 0.26 0.36 
Arachidonic 20:4 ω6 c5, c8,c11,c14 1.78 1.99 2.35 2.81 2.41 0.19 
EPA 20:5 ω3 c5, c8,c11,c14,c17 (EPA) 6.90 6.92 6.18 2.23 5.57 2.97 
Heneicosylic  21:0 0.01 0.01 
    
Docosadienoic 22:2  ω6 c13,c16 0.15 0.19 0.11 0.17 0.11 0.21 
Eranthic 22:3 ω6 c5, c13, c16 0.03 0.02 0.02 0.03 0.02 0.02 
Ardenic 22:4 ω6 c7, c10, c13, c16 0.08 0.07 0.12 0.17 0.11 0.09 
DPA 22:5 ω6 c4, c7, c10, c13, c16 2.53 1.71 4.03 5.74 3.22 2.42 
DHA 22:6 ω3 c4, c7, c10, c13, c16,c19 (DHA) 7.12 5.36 6.57 6.33 7.45 4.63 
Tricosylic 23:0 0 0 0.03 0.03 0.03 0.03 
Lignoceric 24:0 0.09 0.06 0.05 0.04 0.07 0.05 
 Total SFA 36.92              35.91 39.85 36.51 37.64 33.40 
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 Total MUFA 21.17 23.12 23.55 23.67 24.34 21.20 
 Total PUFA 33.84 33.36 32.61 32.17 33.78 23.81 
 Total ω3 PUFA 17.27 16.42 15.96 12.25 16.34 10.88 
 Total ω6 PUFA 16.57 16.94 16.65 19.92 17.44 12.93 









AADLAND, E. K., LAVIGNE, C., GRAFF, I. E., ENG, O., PAQUETTE, M., HOLTHE, 
A., MELLGREN, G., JACQUES, H. & LIASET, B. 2015. Lean-seafood intake 
reduces cardiovascular lipid risk factors in healthy subjects: results from a 
randomized controlled trial with a crossover design. Am J Clin Nutr, 102, 582-92. 
ADILI, R., HAWLEY, M. & HOLINSTAT, M. 2018. Regulation of platelet function and 
thrombosis by omega-3 and omega-6 polyunsaturated fatty acids. Prostaglandins 
Other Lipid Mediat, 139, 10-18. 
ÅGREN, J. J. & HÄNNINEN, O. 1993. Effects of cooking on the fatty acids of three 
freshwater fish species. Food Chemistry, 46, 377-382. 
AL-SAGHIR, S., THURNER, K., WAGNER, K. H., FRISCH, G., LUF, W., RAZZAZI-
FAZELI, E. & ELMADFA, I. 2004. Effects of different cooking procedures on 
lipid quality and cholesterol oxidation of farmed salmon fish (Salmo salar). J 
Agric Food Chem, 52, 5290-6. 
ALBERT, A., VARELA, P., SALVADOR, A., HOUGH, G. & FISZMAN, S. 2011. 
Overcoming the issues in the sensory description of hot served food with a 
complex texture. Application of QDA®, flash profiling and projective mapping 
using panels with different degrees of training. Food Quality and Preference, 22, 
463-473. 
ALEXI, N., NANOU, E., LAZO, O., GUERRERO, L., GRIGORAKIS, K. & BYRNE, 
D. V. 2018. Check-All-That-Apply (CATA) with semi-trained assessors: Sensory 
profiles closer to descriptive analysis or consumer elicited data? Food Quality and 
Preference, 64, 11-20. 
ANSORENA, D., GUEMBE, A., MENDIZABAL, T. & ASTIASARAN, I. 2010. Effect 
of fish and oil nature on frying process and nutritional product quality. J Food Sci, 
75, H62-7. 
ANTONOPOULOU, S., KARANTONIS, H. C., NOMIKOS, T., OIKONOMOU, A., 
FRAGOPOULOU, E. & PANTAZIDOU, A. 2005. Bioactive polar lipids from 
Chroococcidiopsis sp. (Cyanobacteria). Comparative Biochemistry and 
Physiology Part B: Biochemistry and Molecular Biology, 142, 269-282. 
AXELROD, L., CAMUSO, J., WILLIAMS, E., KLEINMAN, K., BRIONES, E. & 
SCHOENFELD, D. 1994. Effects of a small quantity of omega-3 fatty acids on 
95 
 
cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, 
controlled study. Diabetes Care, 17, 37-44. 
BAKAR, J., RAHIMABADI, E. Z. & CHE MAN, Y. B. 2008. Lipid characteristics in 
cooked, chill-reheated fillets of Indo-Pacific king mackerel (Scomberomorous 
guttatus). LWT - Food Science and Technology, 41, 2144-2150. 
BALDWIN, D. E. 2012. Sous vide cooking: A review. International Journal of 
Gastronomy and Food Science, 1, 15-30. 
BASTIAS, J. M., BALLADARES, P., ACUNA, S., QUEVEDO, R. & MUNOZ, O. 2017. 
Determining the effect of different cooking methods on the nutritional 
composition of salmon (Salmo salar) and chilean jack mackerel (Trachurus 
murphyi) fillets. PLoS One, 12, e0180993. 
BHATT, D. L., STEG, P. G., MILLER, M., BRINTON, E. A., JACOBSON, T. A., JIAO, 
L., TARDIF, J. C., GREGSON, J., POCOCK, S. J. & BALLANTYNE, C. M. 
2019a. Reduction in First and Total Ischemic Events With Icosapent Ethyl Across 
Baseline Triglyceride Tertiles. J Am Coll Cardiol, 74, 1159-1161. 
BHATT, D. L., STEG, P. G., MILLER, M., BRINTON, E. A., JACOBSON, T. A., 
KETCHUM, S. B., DOYLE, R. T., JR., JULIANO, R. A., JIAO, L., 
GRANOWITZ, C., TARDIF, J. C. & BALLANTYNE, C. M. 2019b. 
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N 
Engl J Med, 380, 11-22. 
BJORNDAL, B., STRAND, E., GJERDE, J., BOHOV, P., SVARDAL, A., DIEHL, B. 
W., INNIS, S. M., BERGER, A. & BERGE, R. K. 2014. Phospholipids from 
herring roe improve plasma lipids and glucose tolerance in healthy, young adults. 
Lipids Health Dis, 13, 82. 
BLIGH, E. G. & DYER, W. J. 1959. A rapid method of total lipid extraction and 
purification. Can J Biochem Physiol, 37, 911-7. 
BROOKMIRE, L., MALLIKARJUNAN, P., JAHNCKE, M. & GRISSO, R. 2013. 
Optimum Cooking Conditions for Shrimp and Atlantic Salmon. Journal of food 
science, 78, S303-13. 
BURRI, L., HOEM, N., BANNI, S. & BERGE, K. 2012. Marine omega-3 phospholipids: 
metabolism and biological activities. Int J Mol Sci, 13, 15401-19. 
CANDELA, M., ASTIASARÁN, I. & BELLO, J. 1998. Deep-Fat Frying Modifies High-




CHEN, L., DENG, H., CUI, H., FANG, J., ZUO, Z., DENG, J., LI, Y., WANG, X. & 
ZHAO, L. 2017. Inflammatory responses and inflammation-associated diseases 
in organs. Oncotarget, 9, 7204-7218. 
CHOWDHURY, R., STEVENS, S., GORMAN, D., PAN, A., WARNAKULA, S., 
CHOWDHURY, S., WARD, H., JOHNSON, L., CROWE, F., HU, F. B. & 
FRANCO, O. H. 2012. Association between fish consumption, long chain omega 
3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-
analysis. Bmj, 345, e6698. 
COSTA, S., AFONSO, C., CARDOSO, C., BATISTA, I., CHAVEIRO, N., NUNES, M. 
L. & BANDARRA, N. M. 2015. Fatty acids, mercury, and methylmercury 
bioaccessibility in salmon (Salmo salar) using an in vitro model: Effect of culinary 
treatment. Food Chem, 185, 268-76. 
CROPOTOVA, J., MOZURAITYTE, R., BEATE STANDAL, I. & RUSTAD, T. 2019a. 
Assessment of lipid oxidation in Atlantic mackerel (Scomber scombrus) subjected 
to different antioxidant and sous-vide cooking treatments by conventional and 
fluorescence microscopy methods. 
CROPOTOVA, J., MOZURAITYTE, R., STANDAL, I. B., AFTRET, K. C. & 
RUSTAD, T. 2019b. The Effect of Sous-Vide Cooking Parameters, Chilled 
Storage and Antioxidants on Quality Characteristics of Atlantic Mackerel 
(Scomber scombrus) in Relation to Structural Changes in Proteins( section sign). 
Food Technol Biotechnol, 57, 191-199. 
DALUM, A., TANGEN, R., FALK, K., HORDVIK, I., ROSENLUND, G., 
TORSTENSEN, B. & KOPPANG, E. O. 2016. Coronary changes in the Atlantic 
salmon Salmo salar L: characterization and impact of dietary fatty acid 
compositions. J Fish Dis, 39, 41-54. 
DAVIDSON, M. H., JOHNSON, J., ROONEY, M. W., KYLE, M. L. & KLING, D. F. 
2012. A novel omega-3 free fatty acid formulation has dramatically improved 
bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the 
ECLIPSE (Epanova((R)) compared to Lovaza((R)) in a pharmacokinetic single-
dose evaluation) study. J Clin Lipidol, 6, 573-84. 
DEHLHOLM, C., BROCKHOFF, P. B., MEINERT, L., AASLYNG, M. D. & BREDIE, 
W. L. P. 2012. Rapid descriptive sensory methods – Comparison of Free Multiple 
Sorting, Partial Napping, Napping, Flash Profiling and conventional profiling. 
Food Quality and Preference, 26, 267-277. 
97 
 
DEMOPOULOS, C. A., KARANTONIS, H. C. & ANTONOPOULOU, S. 2003. Platelet 
activating factor — a molecular link between atherosclerosis theories. European 
Journal of Lipid Science and Technology, 105, 705-716. 
DIAZ, P., NIETO, G., BANON, S. & GARRIDO, M. D. 2009. Determination of shelf 
life of sous vide salmon (Salmo salard) based on sensory attributes. J Food Sci, 
74, S371-6. 
DIN, J. N., HARDING, S. A., VALERIO, C. J., SARMA, J., LYALL, K., RIEMERSMA, 
R. A., NEWBY, D. E. & FLAPAN, A. D. 2008. Dietary intervention with oil rich 
fish reduces platelet-monocyte aggregation in man. Atherosclerosis, 197, 290-6. 
DYERBERG, J., BANG, H. O. & HJORNE, N. 1975. Fatty acid composition of the 
plasma lipids in Greenland Eskimos. Am J Clin Nutr, 28, 958-66. 
ECHARTE, M., ZULET, M. A. & ASTIASARAN, I. 2001. Oxidation process affecting 
fatty acids and cholesterol in fried and roasted salmon. J Agric Food Chem, 49, 
5662-7. 
ELVEVOLL, E. O., BARSTAD, H., BREIMO, E. S., BROX, J., EILERTSEN, K.-E., 
LUND, T., OLSEN, J. O. & ØSTERUD, B. 2006. Enhanced incorporation of n−3 
fatty acids from fish compared with fish oils. Lipids, 41, 1109-1114. 
ENNS, J. E., YEGANEH, A., ZARYCHANSKI, R., ABOU-SETTA, A. M., FRIESEN, 
C., ZAHRADKA, P. & TAYLOR, C. G. 2014. The impact of omega-3 
polyunsaturated fatty acid supplementation on the incidence of cardiovascular 
events and complications in peripheral arterial disease: a systematic review and 
meta-analysis. BMC Cardiovasc Disord, 14, 70. 
ERKKILA, A. T., SCHWAB, U. S., LEHTO, S., DE MELLO, V. D., KANGAS, A. J., 
SOININEN, P., ALA-KORPELA, M. & UUSITUPA, M. I. 2014. Effect of fatty 
and lean fish intake on lipoprotein subclasses in subjects with coronary heart 
disease: a controlled trial. J Clin Lipidol, 8, 126-33. 
FERRARO, V., CARVALHO, A. P., PICCIRILLO, C., SANTOS, M. M., CASTRO, P. 
M. & PINTADO, M. E. 2013. Extraction of high added value biological 
compounds from sardine, sardine-type fish and mackerel canning residues--a 
review. Mater Sci Eng C Mater Biol Appl, 33, 3111-20. 
FERRARO, V., CRUZ, I. B., JORGE, R. F., MALCATA, F. X., PINTADO, M. E. & 
CASTRO, P. M. L. 2010. Valorisation of natural extracts from marine source 




FOLCH, J., LEES, M. & SLOANE STANLEY, G. H. 1957. A simple method for the 
isolation and purification of total lipides from animal tissues. J Biol Chem, 226, 
497-509. 
GARCÍA-LINARES, M. C., GONZALEZ-FANDOS, E., GARCÍA-FERNÁNDEZ, M. 
C. & GARCÍA-ARIAS, M. T. 2004. MICROBIOLOGICAL AND 
NUTRITIONAL QUALITY OF SOUS VIDE OR TRADITIONALLY 
PROCESSED FISH: INFLUENCE OF FAT CONTENT. Journal of Food 
Quality, 27, 371-387. 
GIACCO, R., CUOMO, V., VESSBY, B., UUSITUPA, M., HERMANSEN, K., 
MEYER, B. J., RICCARDI, G. & RIVELLESE, A. A. 2007. Fish oil, insulin 
sensitivity, insulin secretion and glucose tolerance in healthy people: Is there any 
effect of fish oil supplementation in relation to the type of background diet and 
habitual dietary intake of n-6 and n-3 fatty acids? Nutrition, Metabolism and 
Cardiovascular Diseases, 17, 572-580. 
GIL, A. & GIL, F. 2015. Fish, a Mediterranean source of n-3 PUFA: benefits do not 
justify limiting consumption. Br J Nutr, 113 Suppl 2, S58-67. 
GLADYSHEV, M. I., GUBANENKO, G. A., SUSHCHIK, N. N., DEMIRCHIEVA, S. 
M. & KALACHEVA, G. S. 2006. [Influence of different methods of cooking of 
hunchback salmon on contents of polyunsaturatedfatty acids]. Vopr Pitan, 75, 47-
50. 
GOEL, A., POTHINENI, N. V., SINGHAL, M., PAYDAK, H., SALDEEN, T. & 
MEHTA, J. L. 2018. Fish, Fish Oils and Cardioprotection: Promise or Fish Tale? 
International journal of molecular sciences, 19, 3703. 
GONZÁLEZ-FANDOS, E., VILLARINO-RODRı́GUEZ, A., GARCı́A-LINARES, M. 
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